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ABSTRACT
Protection of Macrophages J774a.1 by Purine Nucleoside Analogues
From B. anthracis Mediated Necrosis
by
Zadkiel R. Álvarez
Dr. Ernesto Abel-Santos, Examination Committee Chair
Professor of Biochemistry
University of Nevada, Las Vegas
Eight years after the lamentable anthrax attacks, major scientific effort continues to
be done, in order to stop imminent acts of bioterrorism. Innovative ways of therapy
against the anthrax disease are being investigated. B. anthracis, the etiological agent of
the infection, has a dormant stage in its life cycle known as the endospore. When
conditions become favorable spores germinate, transforming into vegetative bacteria. In
inhalational anthrax, the most fatal manifestation of the disease, spores enter the
organism

through

the

respiratory

track,

and

are

phagocytosized

by

alveolar

macrophages of the lungs. Spores are able to sense nutrient availability, activating their
germination inside the phagosomal compartment. Germination is a crucial step for the
commencement of the pathogenesis inside the host organism.
B. anthracis germination is activated by a wide variety of amino acids and purine
nucleosides. Inosine and alanine are the two most potent nutrient germinants. Recent
studies have shown that germination can be hindered by isomers or structural
analogues of germinants. 6-thioguanosine, a guanosine analogue, is able to inhibit
germination, and prevent B. anthracis toxin-mediated necrosis in murine macrophages.
Our investigation was focused on the screening of 43 different purine nucleoside
analogues, to determine their protective effects on the macrophage cell line J774a.1. We
have selected a group of 19 compounds that impeded the spore germination in vitro,
and tested their protective effect in cells. Seven of these analogues exerted protective
effect against B. anthracis mediated killing. Structure activity relationships analyses on
those compounds has clarified the mechanisms of the inhibition in cells, and illustrated

iii

a plausible model for the germinant-receptor recognition. Continuous research on this
area should develop a novel antigerminant agent as an immediate prophylaxis to stop
B. anthracis pathogenesis.
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CHAPTER 1
INTRODUCTION
1.1 Background and Significance
Bacillus anthracis is a gram-positive bacterium that has the ability of developing
resistant forms in their life cycle called endospores. Such particular property is present
in a diverse group of prokaryotes, included in the phylum Firmicutes

(1).

Belonging to

this group there are two relevant genera –Clostridium and Bacillus– that are important
pathogens to humans. Endospore forming bacteria have developed several evolutionary
strategies that make them prevail in a wide variety of niches, and infecting multiple
hosts (2,3).
Many species of endospore-forming bacteria are causative agents of important
diseases in humans and also in animals. The possibility of being infected by these
bacteria is increased due to the fact that their spores may survive in almost any
possible environment in our planet

(4),

and may easily disseminate in the environment

through air and water. This added to the fact that many endospore-forming species
produce severe toxins brings up the existence of major diseases: gas gangrene (C.
perfringens), tetanus (C. tetani), pseudomembranous colitis and chronic diarrhea1 (C.
difficile), food-borne and wound botulism (C. botulinum), edematous wound infestation
and enterotoxemia (C. sordelli), food poisoning (B. cereus), and anthrax (B. anthracis)

(3).

Many of these diseases can progress onto severe septicemias when infections are
important, the patient does not receive the proper treatment, or if patient is
immunocompromised. Anthrax is one of the most dangerous infectious diseases

(5).

Only acute hemorrhagic fevers caused by the families of virus Filoviridae (Marburg,

1 Clostridium difficile associated disease (CDAD) is a hospital-borne infection that takes place in
patients that are depleted of the normal micro-flora of the colon due to antibiotic prophylaxis. It
causes pseudomembranous colitis and necrotizing enterocolitis in humans.

1

Ebola) Flaviviridae (Yellow Fiver), or Bunyaviridae (Crimean-Congo fever) are considered
more hazardous, since no specific treatment is available2

(6).

Anthrax has existed in the World for centuries. The disease in cattle is described in
Egyptian and Mesopotamian writings from 5000 B.C.(8) It appears in the Bible in the
book of Exodus (chapter 9) as the fifth (death of livestock) and sixth (boils) plagues sent
by God to Egypt

(9).

Formerly, the disease was associated to a pest that affected

primarily cattle. The appearance of a ‘black eschar’ was characteristic of cutaneous
anthrax. Europe witnessed sporadic outbreaks of anthrax, with the most acute
outbreaks occurring in 14th century in Germany and 17th century Russia and central
Europe

(10).

The people with higher risk of being infected were the farmers that work

with animal hair and wool. In the 18th century inhalational anthrax was known in
England as the ‘woolsorters disease’

(9).

On 1881, Louis Pasteur demonstrated on the

‘Pouilly-Le-Fort trial’ that cows infected with a attenuated strain survived after infecting
with a virulent strain, leading to the first vaccination ever made(3,8-10). In the early
1900s, human cases of inhalational anthrax appeared in United States among workers
in textile industries processing wool. The incidence of the disease decreased
considerably during the 20th (9).
The alarm for anthrax was activated in 1979 at the city of Sverdlovsk, Russia.
During the ‘Cold War’ there were concerns on the investigation of anthrax spores as a
possible biological weapons by both United States and the Soviet Union. The Army
Medical Corps developed in the 1950s the vaccine of anthrax that is licensed at the
present time, the AVA vaccine

(9).

Meanwhile, the Soviet Union was developing highly

virulent strains to use as weapons, until an accident occurred. One worker of the
microbiology facility at Sverdlovsk removed an air filter from the spore drying facility,
and forgot to notify it in the logbook

(11).

Another researcher did not see anything

Many RNA-viruses belong to the Biosafety Level 4 (BSL-4), which includes aerosol-transmitted
agents causing severe to fatal disease in humans for which vaccines or other treatments are not
available. Anthrax belongs to BSL-3, for there is a vaccine and antibiotic treatment available.

2

2

unusual and turned on the machine. After some days a terrible outbreak occurred,
affecting people nearby the facility. 96 individuals developed anthrax by ingesting
contaminated meat or touching infected animals, of which 64 resulted fatal

(12).

This

spore leak was one of the most important accidents related to bio-safety negligence in
history. It has been considered as the ‘Biological Chernobyl’

(11).

The idea of using anthrax as a biological weapon is a potential threat to any
country, specially the United States, victim of several terrorist attacks. Anthrax spores
are very easy to handle and disseminate through the air. The Center of Disease Control
and Prevention (CDC) has defined the different bioterrorism agents that are currently
available

(13).

Bacillus anthracis is included among the highest priority agents in

Category A. This category refers to agents that can be easily disseminated and
transmitted, may result in high mortality rate, and cause panic and awareness.
Just one week after 9-11 attacks, a new alarm broke out the panic in the US
citizens. Letters containing anthrax spores were mailed to several news media offices
and two democratic U.S Senators. The attacks came in two separate waves; the first five
letters were dated on September 18th and were sent to several media offices in New York
(ABC, NBC, New York Post), and Boca Raton, Florida (American Media Inc.). A second
wave of to letters was sent on October 9th to the offices of two democratic senators. The
event resulted in five fatalities and other seventeen people infected

(14).

The case, also

known as Amerithrax3, was considered by the Federal Bureau of Investigation (FBI) the
worst bioterrorist attack ever made inside the United States

(15).

The terrorists were using the Ames strain A2012. This is one of the most virulent
strains of Bacillus anthracis, and it is also vaccine resistant

(16).

It is used in biodefense

laboratories in the United States, in research to “challenge” vaccines4

(16, 17).

After a long

period of investigations, in 2008 the FBI found in that Bruce E. Ivins, a biodefense

3

‘Amerithrax’ was the name that the FBI designated to the 2001 Anthrax attacks

Ames strain was isolated in Texas (1981), as an AVA vaccine resistant strain. Its protective
antigen was used in research to develop more efficient vaccines.

4

3

researcher at USAMRIID, was likely to be responsible for these attacks, and was
charged with the death of five persons and injury of several others. After learning that
federal prosecutors were preparing to indict him, Irvin committed suicide with an
overdose of acetaminophen

(18).

Since the anthrax event occurred in 2001, concerns for biodefense research have
increased worldwide. A considerable number of research groups from public and private
institutions are studying Bacillus anthracis for the good –to find more efficient vaccines
and potential treatments and for the bad –weaponizing the bacteria to make more
resistant and infective spores–(19). The total budget spent by the U.S. Government in
biodefense funding in 2001 was a total of US $576 millions. For 2008, this funding
increased up to US $5,421 millions, almost five billion dollars more than 2001(20).
Many strains of B. anthracis has already been genetically engineered to escape
immunization by vaccines (Ames strain) (16), and to generate antibiotic resistance

(21, 22).

Nowadays, anthrax disease can only be treated with the different antibiotics approved
by the Food and Drug Administration (FDA): ciprofloxacin, doxycycline, and penicillin.
Nonetheless, when the infection progresses to the late stage, antibiotics do not seem to
respond. Recent investigations are focused in finding novel ways of therapies different
than antibiotics and vaccines. In the immediacy of bioterrorism, the development of new
efficient ways of for prophylaxis against B. anthracis is essential, as a way to beat
upcoming sinister attacks, and maintain welfare in World nations.
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1.2 The Anthrax Disease
Bacillus anthracis is the etiological agent of anthrax. The disease is epizootic,
occurring exclusively in mammals. Grazing herbivores are the most susceptible to the
infection: they are more prone to ingest the spores from the soil, which is the main
reservoir

(3,5).

The infection is initiated by the entry of the spores into the host body.

This takes place by four major ways: 1) entry into the tissues through skin abrasions, 2)
via insect bite, 3) by direct ingestion of the spores in the soil or contaminated food
sources, and 4) by inhalation airborne spores. Anthrax can be transmitted from animal
to humans in rare occasions (zoonosis) by direct contact with infected animals or their
products, or by ingestion of contaminated animal food sources. Human to human
transmissions are rare

(5,7).

Depending on the spores’ portal of entry, the disease will progress in different ways
leading to three types of infection: cutaneous, gastrointestinal and inhalational anthrax.
If the infection is localized in one region or tissue, symptoms are minor and the disease
can be controlled. The potential danger of this disease comes when the bacilli invade
the bloodstream. Once the bacteria reach the blood, the infection becomes systemic,
leading to a fatal bacteremia and toxemia that will jeopardize the life of the host
organism.
1.2.1 Cutaneous Anthrax
In cutaneous manifestation of anthrax, B. anthracis endospores penetrate the
tissues of the host organism through skin abrasions or cuts. In few occasions it has
been transmitted through insect bites

(3, 5, 7).

Spore germination will take place at the

primary site, leading to local edema and necrosis. It is not clear, however, if the
germination occurs inside or outside the cells, in the interstitial fluids. In any case, the
spores will germinate, and the vegetative cells will produce the respective toxins.
The primary skin lesion is usually a painless, but pruritic papule that appears 3 to
5 days after the introduction of the spores. Within 24 to 36 hours, the lesion forms a
vesicle that undergoes central necrosis. After drying it leaves a ‘black eschar’
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surrounded by edema, which characteristic and exclusive of cutaneous anthrax. This
eschar must not be confused with a pustule, because is painless and non purulent.
These lesions normally resolve without complications in near 90% of the cases.
Nonetheless, antibiotic treatment is recommended. There is a risk of more severe
complications, such as malignant edema, that is accompanied of shock symptoms and
breathing difficulties when is located in neck or thoracic regions

(5).

Untreated cases have a mortality rate from 10 to 20% in humans

(23).

Cutaneous

anthrax mortality is due to airway obstruction from malignant edemas or by septicemia.
In rare occasions, the spores are phagocytosized by macrophages, and germinate inside
them. The macrophages detach and migrate to regional lymph nodes carrying the
bacilli. These will grow in the lymph node producing hemorrhagic lymphadenitis.
Bacteria will spread through the lymph and blood, increasing rapidly to high numbers
and causing a fatal septicemia and shock

(5).

1.2.2 Gastrointestinal and Oropharyngeal Anthrax
The pathophysiology of gastrointestinal anthrax is very similar to that of cutaneous
anthrax. Following ingestion of spores, the primary site of infection occurs on the
epithelium of the gastrointestinal tract. It is likely that the bacterial inoculation takes
place at a breach in the mucosal lining

(7).

The exact site of germination of the spores

remains unknown. A recent study suggests that B. anthracis endospores can be
internalized by from epithelial cell line Caco-2 isolated from the intestine

(24).

The most common symptom of gastrointestinal anthrax is ulceration accompanied
with enteritis. Associated symptoms include fever, abdominal pain, diarrhea, and bloodtinged vomiting and stools. In some cases mediastinal widening has been observed,
although this symptom is more proper of inhalational anthrax

(3).

Anthrax death results

from intestinal perforation and anthrax toxemia. Mortality rates are considerably higher
than cutaneous anthrax: 25 to 60 percent of the cases that are non-treated. If the
patient survives, the ulceration symptoms start to reside after 10 days
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(3, 23).

A less common for associated with ingestion of contaminated food is oropharyngeal
anthrax is less common. It is normally milder than the intestinal form. Its symptoms
include cervical edema and local lymphoadenopathy, causing respiratory difficulties.
The

lesions

in

the

oropharynx

have

the

appearance

of

pseudomembranous

ulcerations(5).
1.2.3 Inhalational Anthrax
Inhalational anthrax is the most fatal form of infection. Even with aggressive
antimicrobial therapy its mortality rates are high. If the infection becomes systemic, its
mortality is near 100%. The only positive aspect about this manifestation of anthrax is
that does not occur often. It only accounts for less than 5% of the cases usually, since
the infective dose in human is high. In an estimate, a human needs to inhale least
50,000 spores for the infection, although this amount may vary among different
individuals

(3, 25).

After the spores are inhaled, they may reach the bronchioles and alveoli of the
lungs. Alveolar macrophages can efficiently phagocytosize the B. anthracis spores, and
they germinate inside the phagolysosome

(26).

This is the one and only way that the

bacteria will proliferate when spores are inhaled. Hence, germination inside the
macrophages is the key step to initiate the pathogenesis inhalational anthrax.
Although the initial site of contact is the lungs, inhalational anthrax cannot be
considered a true pneumonia. The macrophages will transfer the bacteria to the
mediastinal and peribronchial lymph nodes, where the infection per se begins. When
the macrophages are inside the lymph nodes, the germinated bacilli escape from the
cells by necrosis via toxins or by other mechanisms not yet elucidated

(27).

As it was

mentioned with the other types of anthrax, the bacilli multiply inside the lymph nodes.
The incubation time for inhalational anthrax is from 10 days, but the onset
symptoms do not begin until six weeks. However, the bigger amount of spores in the
inocula, the less the time it will take for symptoms to occcur. After the incubation
period, the bacteria proliferate and secrete their toxins causing a hemorrhagic
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mediastinitis

(5).

Subsequently the bacteria can disseminate through the bloodstream.

In the earlier course of disease the initial symptoms are cough, myalgia, and fever,
resembling those of a viral respiratory disease. Thoracic radiographs show a
mediastinal widening, that is an evidence of hemorrhagic mediastinitis. Mediastinal
widening is indicative of inhalational anthrax and can be used as differential diagnosis,
although the infection its late stage by then. Inhalational and gastrointestinal anthrax
are difficult to diagnose in the early stages of disease due to the nonspecific symptoms.
One to three days after mediastinitis, the latter symptoms appear: acute dyspnea,
cyanosis, diaphoresis, stridor, and coma followed by death

(3, 7, 25).

1.3 Biology of Bacillus anthracis
1.3.1 Traits of the Species
The genus Bacillus is ubiquitous in nature. Most of the Bacillus species are
facultative anaerobes and saprophytes. However, some are opportunistic or obligate
pathogens of animals, including humans, other mammals, and insects

(2, 3, 7, 28).

Bacillus

anthracis was thought to be an obligate pathogen, but recent findings suggest that its
vegetative stage can be present in soil and does not necessarily require an animal host
to survive. The bacteria can be found as vegetative cell in soils of pH~6.0 and
temperatures above 15.5°C (such as limestone) in a cell-spore cycle that may be
maintained indefinitely

(3, 29).

B. anthracis belongs to a highly homogeneous subdivision called the Bacillus cereus
group of organisms that also includes B. cereus and B. thuringiensis. These three
species probably belong to the same ancestor

(1, 30).

B. anthracis and B. cereus are

opportunistic pathogens in mammals, whereas B. thuringiensis is an insect pathogen.
Even though their respective genomes are almost identical, they have notable
differences in the phenotypes.
The most important difference between B. cereus and B. anthracis in their
phenotype is the expression of the capsule of poly-γ-D-glutamic acid, and the exotoxin
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complex. B. anthracis has two plasmids of virulence: pXO1 and pXO2. The ability to
cause the anthrax disease is attributed to such plasmids. Both plasmids together are
required for the pathogenesis. Plasmid pXO1 encodes the genes for the anthrax toxins
(cya, lef, and pagA), whereas pXO2 contains the operon capBCAD that expresses
enzymes for the biosynthesis of the capsule

(31).

1.3.2 The Endospore
All members from the family Bacillaceae have an endosporal phase during their life
cycle

(1-3, 28).

The endospore is a resistant stage of bacteria, in which their cellular

functioning and metabolism are deactivated, entering in a period of rest called
‘dormancy’. Many living organisms enter in dormancy when conditions are unfavorable
for their normal functioning and outgrowth. The normal mechanism of producing a
spore is by a normal cellular division, or ‘mitosis’, in which the pre-sporal cell, or
forespore, will undergo complex genetic changes to develop resistance and enter in
dormancy. The organisms that produce the spore will eventually die. In spore-forming
bateria, the sporal cell develops inside the mother cell, also known as the ‘sporangial
cell’. For that reason bacterial spores are named ‘endo-spores’

(32).

Endospores are

formed in many bacteria in response to starvation. However, some Clostridium species,
such as C. acetobutylicum, are sensitive to other stimulus; the agent that activates the
spore formation in these species remains unknown

(33).

The biological process of spore formation is known as ‘sporulation’ or ‘sporogenesis’.
The bacterial sporulation consist of two major stages: first, there is a process of cellular
division, by which a protoplast is formed within the cytoplasm of the cell. Secondly, it is
an ordered developmental process in which to main layers, cortex and coats are laid
down on the spore protoplast

(32).

Nutrient limitation seems to be the most significant stress that triggers spore
formation in Bacillus

(32, 34).

Different kinases can recognize nutrient limitation. In

Clostridium sp., signals that trigger germination are diverse and are not necessarily
caused by of nutrient limitation. Starvation by carbon, nitrogen, or phosphorus induces
9

the activation of a master transcription regulator called ‘Spo0A’. Five different histidine
kinases (KinA-E) are sensitive to oxygen levels and redox potential. The activation of
these kinases starts up a phosphorylation cascade phophorylating the protein Spo0F,
which subsequently phophorylates and activates Spo0A

(34).

Spo0A activates multiple loci, required for the next step of sporulation: the
asymmetrical division. First the bacterial chromosome replicates, forming two nucleoids
disposed in an axial filament across the cell (Stage I). Afterwards, the cell membrane
undergoes an invagination in and forms the spore septum that separates the two
nucleoids (Stage II). Soon after the division, two distinct programs of gene expression
are initiated: one for the pre-spore and another for the mother cell. These programs are
directed by sporulation-specific RNA polymerase σ-factors; σE in the forespore (prespore), and σF in mother cell. After the division, subsequent proliferation of the cell
membrane of the mother cell, will lead to the engulfment of the pre-spore. The
immature spore is now completely surrounded by a double membrane, and is released
as a protoplast into the mother cell (Stage III).
After the engulfment there is another change in the transcription, and the
transcription factors σG and σK become active in the pre-spore and mother cell
respectively. The pre-spore will eventually become the core of the spore and the mother
cell is responsible of synthesizing the outer protective layers of the spore. Cortex
material begins to be laid down between the double membranes of the protoplast. At the
same time, 2,6-pyridinedicarboxilic acid (dipicolinic acid, DPA) is synthesized and
accumulates inside the core associated calcium cations (DPA-Ca2+). Stage IV is
completed after the formation of the cortex

(28, 32, 34).
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Figure 1. Stages of the sporulation of Bacillus sp. In the initial stage the vegetative cell
will activate the factor Spo0A as a result of initiation signals (Stage 0). Spo0A
combined with another factor (σH) will trigger the asymmetric division of the
cell (Stages I-II). Subsequently two different factors (σE and σF) will lead a
compartmentalized gene expression in the forespore and the mother cell. A
series of proteins that will be encoded in the mother cell will trigger the
migration of the membrane around the forespore has been engulfed (Stage
III). A second set of transcription factors (σK and σG) will activate expression
of new genes in each cell, leading the synthesis of the spore cover. First the
cortex is synthesized (Stage IV), followed by the assembly of the coat proteins
(Stage V). Finally the spore completes is maturation that is observed by the
increase in refractivity (Stage VI) and the sporangial cell is lysed, releasing
the mature spore (Stage VII). Adapted from Prescott, L., Harley, J. et Al
(2000) “Microbiología”. McGraw Hill Press. Spain.

During stage V, coat proteins encoded by the cot genes of B. subtilis are
synthesized. The coat proteins are deposited around the pre-spore. Coat assembly is an
ordered complex process that involves several genes

(35).

The proteins SpoIVA and CotE

from B. subtillis have been well analyzed; SpoIVA function is related to attachment of
the coat to the cortex, and CotE forms a shell around the coat to cover and harbor all
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the coat proteins and enzymes that will be inactive during the spore dormancy. Some
species, such as B. anthracis, form an additional covering for the coat, known as the
exosporium; its function is not well known yet. Finally, the spore matures becoming
resistant to heat, and organic solvents, and lytic enzymes lyse the sporangium or
mother cell, liberating the spore

(3).

The bacterial endospore is a structure of significant complexity, divided into several
layers (see figure 2). A full mature spore is composed of parts that were originated in the
forespore and in the mother cell. The main structural parts are detailed as follow:
Core.- It is the innermost part of the spore. It corresponds to the developing
forespore, inside the sporangial cell. It contains the cytoplasm, DNA, ribosomes,
enzymes and everything that is needed to function once returned to the vegetative state.
It has a very low water content (25-50%), and large amounts of calcium cations and
2,6-pyridinedicarboxilic acid (DPA), that provides resistance to heat, desiccation, and
reactive oxygen species (ROS) . One unique feature is the presence of SAPS proteins
binding the DNA, crucial for the resistance to UV radiation

(32, 36).

Inner membrane.- Is the former plasma membrane of the forespore. It contains
several membrane proteins synthesized during the sporulation that contribute to the
process of germination (ion channels, germination receptors).
Germ cell wall.- The cell wall corresponding to the forespore, and composed mostly
by peptidoglycan, similar to the one of Gram-positive vegetative cells.
Cortex.- The cortex is a very thick low density layer that surrounds the core. It is
mainly composed of modified peptidoglycan. This layer is synthesized during the
sporulation, between the outer membrane from the mother cell, and the inner
membrane of the forespore.

It is important for the maintenance of the spore’s
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dehydrated state
the spore

(37).

The cortex is also associated with the property of refractivity5 of

(32).

Coat.- It is a dense proteinaceous multilayered-cover. It is synthesized in the late
stages of sportulation on the outer membrane from the mother cell that engulfs the
forespore.

Al least 30 different protein species compose the coat

(35).

It provides

mechanical integrity and defense against toxic molecules, by excluding large-sized
molecules and allowing small nutrients that are needed for activating the germination.
It also carries several enzymes involved in the detoxification and a cortex-specific lytic
enzyme (CwlJ)

(36, 37).

It is divided into two layers of proteins (outer and inner coat)

separated by a shell made of the protein CotE

(35).

Exosporium.- In some species of Bacillus, including B. anthracis, the coat is
supplemented with a glycoprotein cover. It serves as a semi-permeable barrier that
excludes large, potentially harmful molecules, such as antibodies and hydrolytic
enzymes. It has an external hair-like filament layer, composed mostly of the collagentype glycoprotein BclA

(38).

It has been found recently that the exosporium contains the

enzyme alanine racemase (Alr), for the auto-regulation of the spore germination

(39).

The

exosporium is likely to be an important recognition site in the spore. BclA has ben
shown to stimulate phagocytosis by macrophages

5

(40).

The refractivity or refractility of the spore is also known as the whitening of the spore. It is
correlated in part to the calcium DPA intake but also with the synthesis of coat proteins. When a
spore appears particularly bright when is viewed by phase-contrast or light microscopy it has
become ‘refractile’. This property is lost with cortex-less mutants. (3,32)
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Figure 2. Morphology of the Endospore

Endospores are resistant to extreme conditions. They can survive to almost any
environment present in our home planet, and it has been shown that they may resist
environments outside the Earth

(4).

They exhibit resistance to many agents physical

agents, such as extreme heat of over 100°C, solar UV radiation (both UV-A and UV-B),
γ-radiation, extreme desiccation, high hydrostatic pressure (near 200 atm), and even
cosmic ionizing radiation. Even more, it can survive action of many toxic chemicals,
including organic solvents, alkylating and oxidizing agents.
The spore coat is relatively impermeable, preventing the entry of damaging
molecular agents. However, this impermeability is limited; some chemicals involved in
the germination of the spore are able to penetrate the coat and the cortex binding
receptor on inner membrane.
Besides the resistance to any hostile environment, endospores show an incredible
longevity. They may remain dormant for hundreds of years. A few cases have obtained
environmental samples of spores from up to 105 years, and they were able germinate. A
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sample of viable B. sphaericus spores was obtained from fossilized Dominican amber
dated of about 25 million years

(41).

Several proteins, located in the core and coat, contribute to their resistance and
longevity of the spores. Small acid soluble proteins play an essential role for the
maintenance of DNA inside the core and the protection of dormant enzymes that need
to be reactivated upon the germination

(42).

Coat proteins are also crucial for the

protection of the lytic enzymes associated with the coat and cortex degradation in the
germination

(35).

Other mechanisms of protection include DNA repairing enzymes, high

cation concentration, low water content, and the presence of DPA. Mutant B. subtillis
strains lacking the genes for the DPA sythetase (dpaA, dpaB) showed increased water
content and less resistance to heat

(43).

1.3.3 Pathogenesis and Host Cell Interactions
The pathogenesis of B. anthracis relies in the capsule and the tripartite toxin
combination. The toxins belongs to the family of bacterial binary A-B toxins,
characterized by a B moiety that binds the target cell, and an A moiety that translocates
into the cytosol. The ‘B’ unit is called protective antigen or PA. The ‘A’ has two
alternative subunits: the lethal factor (LF), and the edema factor (EF). The molecular
mechanisms by which these toxins interact to produce the virulence in the host cells
have been elucidated in the past two decades

(44).

a) Protective antigen (PA):
The protective antigen binds the anthrax toxin receptor (ATR). ATR
proteins are ubiquitous in different mammalian tissues. Two different
forms of ATR have been found in humans: ATR1 and ATR2

(45).

Upon

the binding, PA is activated proteolytically by a furin-like cell-surface
membrane protease. The N-terminal fragment of 20 residues (PA20) is
cleaved. The C-terminal domains (PA63) remain bound to the ATR and
self-associate in the membrane forming symmetric, ring-shaped
heptamers.

The

PA63

heptamer
15

shows

specific

protein-protein

interaction with EF and LF, binding a maximum of three EF/LF
molecules. The next step is the internalization of the toxins into the
cells by ATR-mediated endocytosis. The endosomal compartment will
be acidified by the lysosomal action inside the cell. This decrease in
pH will trigger a conformational change in PA63 heptamer, allowing
the insertion in the membrane and the formation of cation-selective
channels. The channels will now lead the translocation of the EF/LF
units into the cytosol

(44).

b) The lethal factor or lethal toxin (LF):
LF is a four-domain Zn2+-metalloprotease. The mature protein
contains 776 residues. It has been found recently that LF cleaves the
N-terminus of mitogen activated protein kinases (MAPKK) Mek1 and
Mek2

(46).

This cleavage will result in the loss of function by the

MAPKK and the alteration of several transduction pathways in the
cell. This is correlated to the inhibition of the expression of tumoral
necrosis factor alpha (TNF-α), interleukin-1-beta (IL-1β), and release
of pro-inflammatory mediators and nitric oxide. This will result in the
loss of functioning and regulation inside the cell, triggering a rapid
and selective apoptosis

(44).

c) Edema factor or Edema Toxin (EF):
EF is a calcium-calmodulin dependent adenylate cyclase. The mature
protein contains 776 residiues. Upon the translocation from the
endosome, EF remains associated to the endosomal membrane.
Eukaryotic adenylate cyclases are also membrane-associated. EF
converts intracellular ATP into cAMP. This will lead to a substantial
increase in the intracellular cAMP, upsetting water homeostasis and
disrupting the signaling pathways, followed by membrane damage
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and cell necrosis. EF is also the responsible for the edema symptom
in cutaneous anthrax, therefore its name

EF
PA

(7, 44).
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Figure 3. Cellular mechanism of the anthrax toxins. The toxins are released by the
vegetative bacteria. The ATR receptors (ubiquitous in mammalian cells) will bind
the protective antigen. A furin-like endoprotease in the membrane cleaves the PA,
and the remaining fragment (PA63) is oligomerized forming a heptamer. Toxins LF
and EF bind the heptamer, and this complex enters the cell by endocytosis. The
decrease in pH inside the lysosome will trigger a conformational change in the PA
subunits, forming a pore in the membrane, and allowing the binary toxin to enter
into the cytosol. EF will act as a membrane calmodulin-dependent adenylate
cyclase, increasing dramatically the concentrations of AMPc, and upsetting cell
signaling and homeostasis. LF cleaves the MAPKK resulting in the loss of
functioning and subsequent apoptosis or necrosis. Adapted from Mock, M. et al
(2001) Annual Rev Microbiol 55: 647-671

Bacillus anthracis is an extracellular pathogen. However, it appears to require an
intracellular step to initiate infection, at least for inhalational anthrax. Macrophages
serve the bacteria in two ways: as a medium for the spore to germinate, and as vehicle
to penetrate the mucosal barrier and migrate to the lymph nodes. In vivo studies by
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Guidi-Rontani and colleagues have shown that the germination of the endospore takes
place inside the phagolysosome of alveolar macrophages. These cells play an important
role in the cell-mediated immune response preventing the invasion of bacteria entering
through the respiratory tract. Nonetheless, macrophages are ‘deceived’ by B. anthracis
spores, becoming their allies. Guidi-Rontani refers to them as the ‘Trojan horse’ for the
anthrax pathogenesis

(47).

Anthrax spores that reach the alveoli can be readily phagocyted by the
macrophages. Recent research has shown that macrophages show a tropism for the
spores mediated by the integrin Mac-1. This protein is express by different macrophage
cell lines and binds with a high affinity the exosporium protein BclA

(40).

The spore

protein can be considered as a virulence factor. Moreover, endospores can also be
opsonized by C3 proteins, activating the classical pathway of the complement, upon the
binding of IgG

(48).The

combination of the action of the integrin and the opsonization

with C3 enhances phagocytosis of by macrophages.
The toxins that are produced by B. anthracis upon the germination may also
enhance the leukocyte extravasation and further macrophage and neutrophil infiltration
into the alveolus lumen. EF appears to stimulate the production of the proinflammatory IL-6

(49).LF

is likely to stimulate the expression of IL-1β and TNF-α by

macrophages.
The mechanism and germinants by which the endospore germinates inside the
phagosomal compartment are not clear. Guidi-Rontani found that the gerX operon is
not crucial but contributes considerably to germination in macrophages

(26).

J. D.

Ballard and colleagues, from the University of Oklahoma, have identified several genes
in B. anthracis that are required for the germination in vivo

(50).

Mutants in the gerH

operon as well as in the pga gene are unable to germinate the cells. This shows that the
protective antigen is also involved in the germination within the cell. Moreover they have
identified five genes that are differentially expressed upon the phagocytosis. Many these
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genes remain putative, and its function needs to be elucidated

(50).

Thus, the

germination mechanism in cells appears to be complex, involving several proteins.
Once

the spores germinate, the vegetative bacilli can survive inside

phagolysosome

(26, 51).

the

The bacteria need to escape from the action of digestive enzymes

(lysozyme), oxidative stress (ROS), and extremely low pH; they must express genes to
evade the lytic activity of the lysosomes. Other Gram-positive bacteria, such as
Streptococcus sp. can be killed and digested inside the phagolysosome. Dixon and
colleagues demonstrated that B. anthracis can germinate survive in the phagosome
without pXO1 and pXO2, showing that neither the toxins nor the capsule are required
for evading lytic action of the lysosomes

(51).

The identity of the phagosomal protective

genes remains to be elucidated.
Recent studies by Shatalin et al. propose a mechanism by which the bacteria escape
the action of the lysosomal action. There is a latent oxidative stress system present in
the spore and does not require de novo protein synthesis. The bacterial spores have
their own bNOS enzyme that is activated upon the germination producing nitric oxide
(NO). The spores have also the catalase enzyme present (Kat). Both Kat and bNOS will
cooperate against antimicrobial ROS secreted by the macrophage. The NO produced by
bNOS activates Kat and also prevents DNA damage from ROS by suppressing the
Fenton reaction. Kat will catalyze the conversion of the damaging superoxide anions
into water molecules. By studying defective mutants of bNOS, this NO-mediated defense
system has been shown to be essential for the survival inside the phagosome
B.

anthracis

pXO1/pXO2

defective

mutant

spores

are

capable

(52).

of

being

phagocytosized and germinate inside the phagolysosome, but the vegetative cells cannot
escape from this compartment. It has been shown that the phagolysosomal escape
requires a gene from pXO1, which is the positive regulator atxA

(51).

This gene regulates

the expression of many other genes essential for the virulence: it activates the
expression of the operon capACB for the capsule, and the gene pga for the protective
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antigen; indirectly it also activates the expression of the remaining toxin genes, let and
cya

(53).

Dixon and colleagues have observed through microscopy the behavior of four
different strains of B. anthracis spores. Dixon and colleagues have observed through
microscopy the behavior of four different strains of B. anthracis spores. The first two
strains were ΔSterne 7702 (plasmidless), and UT60 (pXO1+, atxA-null). These strain are
not able to escape efficiently from the phagolysosome and their vegetative cells
proliferate and accumulate inside the macrophages until the overabundance of cells
destroy the macrophage membranes by mechanical action. The third strain, RP-31, is
pOX1+/atxA+, but does not carry the let genes for the LF and produces no detectable
amounts of PA. In the observations with RP-31, the strain was released from the
macrophages efficiently; due to the lack of virulence toxins the integrity of the
macrophages was maintained. The last strain was a regular Sterne TCC-013 strain
carrying pOX1+/atxA+ without alteration in any of the genes expressing the toxins. In
this strain the vegetative bacilli escaped the phagolysosome via an atxA-regulated
factor. When they were inside the cytosol the macrophage membrane integrity was
disrupted, likely because of the action of the toxins. The studies show that atxA is
required for the phagosomal escape, and the gene let of the letal factor is not involved
directly in this process

(51).
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Figure 4. Evolutionary strategies developed by B. anthracis in the interaction with the
host cell.

1.4 Spore Germination
1.4.1 Biochemical Stages of Bacillus Germination
Endospores are transformed into vegetative cells by a biochemical and physiological
process called germination. Bacillus sp. endospores germinate when environmental
conditions are favorable. These conditions are mainly nutrient availability, temperature,
and pH

(32).

Even though the spores are dormant and metabolically inactive, they must

be sensitive to the stimulus of germination. This is stimulus is given by certain
nutrients in the environment. These nutrients will act as signaling molecules for the
germination pathway; therefore they are known as ‘germinants’.
Germination is initiated by a signal transduction process that occurs in the
endospore. Germinants will bind transmembrane proteins located around the core, and
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beneath the coat and exosporium of the spore. This family of proteins is also known as
Ger receptor proteins

(54, 55).

The germination process can be summarized in five main events (figure 5):
1) Binding and recognition of signaling molecules to activate the germinaton
receptors.
2) Signal transduction across the cell to produce the germination response.
3) Release of dipicolinic acid (DPA) and rehydration of the spore core.
4) Degradation of the spore cortex and core expansion.
5) Outgrowth and maturation of the core into vegetative cell.

1
Figure 5.

2

3

4

5

Sequential steps involving the germination of the endospore. When signaling
molecules (amino acids and nucleosides) they will bind and activate the specific
Ger receptor protein (1). The receptor triggers a signaling pathway (2) that leads
to DPA release and rehydration of the core (3). Proteases and hydrolases are
expressed for the degradation of the cortex (4). Finally cells recover their
functionality, and acquire a morphology proper of the vegetative state.

Each of these events occurs in a sequential order. The first event is the recognition
of the germinants (amino acids, monosaccharides, and/or nucleosides) that will bind
and activate heterotrimeric receptor proteins. The mechanism for the activation and the
functionality of each of the subunits of the Ger proteins are not yet well understood. It
has been hypothesized that receptors may have more than one site of recognition, and
may serve not only in the signal transduction, but also with an immediate response
acting as a membrane transporters

(55).

In wild type strains in normal physiological
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conditions, once the receptors are activated, spores are committed to germination and
all of the subsequent events will continue until the full maturation of the cell. Studies
show that over 80% of B. anthracis Sterne strain endospores germinate within five
minutes in nutrient broth at 37°C (see table 1)

(56).

Table 1. Heat resistance and optical density
changes during germination
Time
germination
(min)

Heat resistant
CFU6 (%)

OD7550

0
5
10
15
20
30
45

106.0
12.5
7.0
3.5
2.3
1.0
0.3

0.232
0.203
0.137
0.158
0.173
0.148
0.184

Source: E. Abel-Santos et Al (2006)

Ger proteins are located in the inner membrane. In order to initiate germination,
germinant has to permeate the exosporium, coat and cortex layers of the spore and
bind to a germination receptor located in the inner membrane. This requires the
existence of special system. Recently, the role of the locus gerP of B. subtilis and B.
cereus has been elucidated. The GerP protein plays an important role for the
accessibility of nutrients into the spore core. Mutant strains lacking gerP show a poor
rate of germination. When these strains are decoated, the germination is similar as the
one of wild type strains, suggesting that GerP contributes to the access of germinants to
the receptors

(57).

Little is know on the mechanism of signal transduction that triggers expression of
the cortex degradative enzymes and spore permeability. Signaling for germination must

Heat-resistant CFU is a parameter that correlates directly with the concentration of endospore
present in a suspension. After heat-treating a sample only endospores may survive, whereas
vegetative cells are killed.

6

Optical Density (OD) in the range of 520 to 600 nm is a parameter used to determine the spore
concentration in one sample. OD

7
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lead to two final responses in the spore: 1) rehydration of the core, after the dormancy
accompanied with the release of DPA, and 2) expression and/or activation of enzymes
for the degradation of the cortex, for the subsequent growth of the vegetative cell. These
enzymes are mainly proteases and hydrolases

(58, 59).

It is clear that water and cation transport is an early and likely essential event in
the germination. Studies with specific drugs that block K+, Na+, and Ca2+ channels,
inhibited the germination in B. megaterium

(60).

It is hypotesized that the ion channel or

at least one of them may be the Ger protein itself. GerA β-subunits have a sequence
homology with integral membrane proteins that function as transporters.
Major effort to improve our understanding of the biochemical responses in the
immediate events in the germination have been done in the recent years by Peter Setlow
and colleagues. They developed mutants of B. subtilis that are unable to complete
germination and are blocked at an intermediate stage. One of the very first responses is
the release of protons (H+), monovalent cations, and Zn2+. This will lead to a change of
pH in the core from ~6.5 to 7.7, essential for reactivating the spore metabolism

(61).

Subsequently the large depot of DPA inside the spore is released associated with Ca2+
cations; this suggests the existence of DPA channels. Recently, it has been elucidated
the identity of the gene spoVA, that is involved in the DPA uptake for the sporulation
62).

(59,

It is unclear if these proteins are also involved in the DPA efflux outside the core.

DPA release and water influx occur simultaneously through ion water exchange. GerN
is a protein found in B. megaterium; it is a Na+/H+-K+ antiporter. Mutants defective in
gerN are able to grow and sporulate efficiently, but they are unable to germinate. It is
believe that this antiporter plays a crucial role in the cation transport for the
germination

(63).

The second major response that follows ion transport and DPA release is the cortex
degradation. The degradative enzymes are likely to be dormant state inside the core. It
is not clear whether they are activated through rehydration, changes in pH or salinity,
or by direct signal transduction led by Ger receptor. The possibility of expression of lytic
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enzymes de novo is remote, since mRNA synthesis does not take place until the latter
events of outgrowth and maturation. It has been that demonstrated that two cortex
hydrolases are synthesized during sporulation in the forespore

(55),

confirming the idea

that the enzymes are already present in the endospore.
There are two major group of lytic enzymes: spore cortex lytic enzymes (SCLEs) and
cortical fragment lytic enzymes (CFLEs). SCLEs are hydrolases that target specific
components of the peptidoglycan of the cortex. CFLEs are hydrolases of the
polysaccharide moiety. Some of the enzymes have already been elucidated. The
peptodoglycan layer is degraded by different hydrolases. In B. subtilis two enzymes CwlJ
and SleB have been studied. Both required one component of the peptidoglycan for
their action –muramic-δ-lactam–. SleB shows a transglycolase lytic activity, whereas
CwlJ activity is unknown

(59).

Once the cortex is fully degraded the core will complete its

expansion; when this happens the spore starts to lose its dormancy and metabolic
activity is reactivated.
In the outgrowth stage the cell begins to recover the rod shape characteristic of the
vegetative bacteria. A large depot of small acid soluble proteins (SASP) that make up 1020% of the content in the core, needs to be digested for full maturation. SASPs maintain
the integrity of molecules in the core, such as DNA, and other proteins. SAPS
degradation does not begin until the cortex is destroyed and the core is fully expanded
(58, 64).

Macromolecular synthesis is reactivated also during the outgrowth. SAPSs are
cleaved into oligopeptides by the germination protease (GPR). Other spore peptidases
degrade the peptides into amino acids that will be used for the upcoming protein
synthesis. The DNA shielding by the SAPSs is now removed. Transcription of mRNA
begins within the first minutes of the germination. Protein synthesis immediately
follows transcription taking place almost at the same time. However, DNA replication
does start until 30-60 minutes later

(58, 65).
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One phenotypical trait of maturation, observable with optical microscopy, is the loss
of refractivity, as well as the decrease in optical density in suspension. This is due to
the degradation of the cortex. Loss of refractivity is correlated with a decrease in optical
density; this is particularly useful to monitor spore germination in vitro

(3, 32).

1.4.2 Germination Receptors
Ger receptors have been well studied in the present decade

(66-71).

Ger receptors are

encoded in tricistronic operons. It has been assumed that the three proteins encoded
form a complex in the membrane for recognition of the ligand and initiation of the
signaling cascade for the germination. All three receptor subunits are essential for the
germination

(55).

Mutational analysis of different Bacillus species has been done to

determine relevance of each of the three subunits

(67,68, 70).

Core

Inner membrane

Cortex
GerAB

Figure 6.

GerAA

GerAC

Topology and localization of the tripartite protein
encoded by the gerA operon in B. subtilis.
Adapted from Moir, A., Corfe, B. M., and
Behravan, J. (2002) Cell Mol Life Sci 59, 403.
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The ger operon family is ubiquitous among a wide range of species of endospore
forming gram positives. Genes ger have been identified in B. subtilis
(72),

B. anthracis

(68, 69)

(table 2) B. halodurans

(73).

(66, 70, 71),

B. cereus

With the local alignment search tool

(BLAST) searches have revealed analogs of GerA in Clostridum, the other major genus of
endospore forming bacterial: C. difficile, C. acetobutylicum, and C. pasteurianum

(59).

Bacillus subtilis operon gerA (figure 6) serves as the quintessential model for being
the first ger operon functioning to be elucidated

(70, 71).

So far, five different putative

operons for receptor proteins have been identified. Three of them (gerA, gerB, and gerK),
have been characterized

(66).

All three components encoded by this operon are

membrane associated.
The protein GerAA has a domain of five or six membrane segments, plus a large Nterminal and C-terminal hydrophilic domains. The N-terminal domain is believed to be
located inside the spore core, and it likely serves in signaling germination across
membrane. The GerAB protein is predicted to have a motif with 10 transmembrane
helixes. It is likely to be an integral membrane protein due to its high hydrophobic
nature. Mutations within the membrane spanning elements affect the amount of
concentration of germinant (L-alanine) required for germination. Therefore, this protein
appears to affect the receptor-ligand binding. The GerAB and its homologues belong to a
subfamily of the APC (amino acid/polyamine/organocation) superfamily of integral
membrane transporters. The GerAC is a hydrophilic protein. However it is predicted to
have a lipoprotein signal sequence. The protein will be anchored to the inner membrane
due to an N-terminal lipid moiety attachment

(58, 59, 66).
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Table 2. Identified genes for the ger operon in different species of Bacillus
Organism

Chromosomal

Plasmidic

B. subtilis

gerA, gerB, gerK, gerC † gerD†,gerF†,
gerP ‡

B. anthracis

gerA , gerH, gerK, gerL, gerS, gerY

B. cereus

gerB *, gerH, gerI, gerK* , gerL,
gerQ, gerR, gerN‡ , gerS* , gerT‡

††

††

gerX

Former putative genes first identified as involved in germination, but with a
different function.
††
Functionality remains putative.
‡
Gene involved in the germination, but not as germination receptor.
*
No direct phenotypic evidence on the function.
†

1.4.3 Germinants and Germination Pathways
Germinants are known as specific chemical compounds that trigger the germination
of bacterial endospores. In 1949 Joan F. Powell performs the first published studies of
the germination of B. subtilis in vitro, in a phosphate buffer containing L-alanine

(75).

In

the same year, Hills showed that the germination of B. anthracis was influenced by Lalanine, tyrosine, and adenosine

(76).

Germinants are extremely diverse among the Bacillus and Clostridium species. This
is due to the variety of receptors that perform the same function. Although amino acids
are the most common among Bacillus, sugars and nucleosides may also trigger the
germination. Receptors are triggered by one sole germinant, or by two acting together:
co-germinants.

Some receptors just require one of the co-germinant is required to

trigger the signaling cascade, whereas some other need the presence of both cogerminants together

(58, 59).

In each species of bacteria multiple Ger receptors recognize a diverse array of
germinants.

This diverse set of nutrients allows bacteria to germinate in different

micro-environments and to distinguish between soil and host, to break the dormancy.
There is a cooperative response when two or more receptors of different kinds are
triggered at the same time

(59, 68).

This cooperation may ensure that dormancy is broken,

only when environmental conditions are favorable for growth. In B. anthracis efficient
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germination is achieved only with two or more receptors acting together. Multiple
germinants indicate the presence of multiple nutrients which will be needed for the
vegetative cell.
P. Hanna and colleagues have done comprehensive studies on the germination
receptors of Bacillus anthracis and their germinants during the present decade. The
operon gerH was the first one to be studied, due to its significant homology with gerI of
B. cereus. Even though the two receptors are quite similar and respond to the same
germinant – inosine –, they do have some differences. GerH is unable to trigger
germination with inosine only, but needs also an amino acid co-germinant, whereas
GerI only requires the nucleoside. GerH is also required for the germination within
macrophages. Other six ger operons have been indentified in B. anthracis (table 2):
gerA, gerK, gerL, gerS, gerX, and gerY. Frame shift mutations of gerA and gerY have no
detectable effect in the germination in vitro. The rest of the mutants recognize a different
set of amino acid and nucleosides leading to different pathways for germination

(68, 74).

P. Hanna has proposed a model of the different germination pathways in vitro by
analyzing the kinetics of different mutants in each of the Ger receptors

(68).

These

pathways are the following:
a) L-Alanine mediated pathway.
This pathway is triggered by the presence of L-Ala alone in high
concentration (1-10 mM), and requires both GerK and GerL receptors. This
very same pathway will also take place with the prescence of L-Pro and LAla in lower concentrations (AP pathway).
b) Aromatic amino acid-enhanced alanine pathway (AEA).
The AEA response requires GerL, GerS, and GerH. GerS is a recognition
site for aromatic amino acids, but it cannot be triggered alone. It requires
the presence of GerH. This pathway also requires the activation of GerL
with L-Ala to start up the signaling for germination.
c) Amino acid and inosine dependent pathway (AAID).
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This pathway needs an amino acid and a purine nucleoside acting together
as co-germinants. Inosine and adenosine are the most potent purine cogerminant. AAID pathway involves multiple receptors that are combined in
pairs or triplicates for the response. There two AAID responses. AAID-1
includes the binary combination of inosine and either L-alanine, L-serine,
L-valine, L-methionine, or L-proline. It requires the presence of GerH for
nucleoside recognition in combination with GerK, or in combination with
GerL, and another receptor that can be either GerS or GerX.
GerX is located in the plasmid of virulence pXO1 and plays an important role for
the germination in vivo. It has been shown that gerX null mutants are less virulent.
Their rate of germination in macrophages after 3 hours is 70% less than wild type
Strene strains. GerX appears to be involved in the detection of specific germinants
inside the macrophages

(69).

AAID-2 needs the binary combination of L-histidine or aromatic amino acid and a
purine. This route requires both GerH and GerS, with no detectable contribution from
either GerK or GerL. AAID-1 and AAID-2 show different kinetics; the latter one also
needs a higher concentration of the nucleoside to be effective.
Bacillus anthracis may germinate just in the presence of L-Ala, by triggering the
alanine pathway. The rate of germination, however, is considerably slow. With 0.5 mM
L-Ala the mean decrease in OD600 is only 2.5% after 30 minutes. When alanine is added
in combination of inosine the decrease in OD600 is near 60%. In this case at least three
more pathways are activated:

AAID-1 activating the two different combinations of

receptors (GerHSL and GerHSK), and AAID-2 (figure 7). The best rate of germination of
B. anthracis is with the combination of a nucleoside such as inosine or adenosine, and
alanine

(74).
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AAID-1
Ser/Val
+ Purine

Pro/Met +
Purine

Ala + Purine

GerK

GerL

GerS/
GerH
GerX

GerS/
GerH
GerX

His/Aromatic
+ Purine

GerL

GerH

Germination

High Ala /
Low Ala +
Pro

GerK

GerS

AAID-2

ALANINE/AP

GerS
GerL

GerH

Alanine +
Aromatic

Figure 7.

AEA

Germination pathways for B. anthracis. All the pathways need the
combination of two or three Ger proteins to trigger the germination.
Nucleoside dependent pathways are AAID-1/AAID-2; the remaining
pathways require L-alanine alone or combined with other amino acids.
Fisher, N., Hanna P. (2005) J. Bacteriol. 187 (23): 8055-8062.

1.5 Germination Inhibition
Germination is an essential step in B. anthracis for the development of the
pathogenesis

(27).

Inhibiting the germination is a potential target for anthrax

prophylaxis. By understanding the mechanism and biochemistry of the germination, it
is possible to alter the functioning of the proteins that are involved in the pathway.
Blocking the germination is a way for preventing, not only anthrax, but any of the
Bacillus and Clostridium associated diseases; germination inhibition in food-borne
pathogens such as B. cereus(77), B. megaterium
perfringens

(80),

(78),

Clostridium botulinum

(79),

C.

and B. subtilis(82) has been investigated previously.

Several ways for preventing germination have been studied. It has been shown that
alkyl alcohols blocked the in vitro germination in B. subtilis, B. cereus, and B.
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megaterium

(82).

Many other ways of inhibition include protease inhibitors

channel blockers

(60),

and sulphydryl reagents

(84).

(83),

ion-

The most common way to block the

germination is preventing the activation of the spore by nutrients or germinants

(85).

D. Cortezzo and colleagues have studied the action several molecules that are able
to inhibit the germination in B. subtilis. These compounds block the germination by
nutrients before DPA release

(85).

Such inhibitors can be grouped into two categories.

The first group has compounds that inhibit L-alanine-triggered germination, but have
no effect on B. megaterium or on germination with mixed nutrients; they respond to a
specific nutrient receptor. In this division are many alkyl alcohols, N-ethylmaleimide,
nifedipine, phenols, and potassium sorbate. The second group includes agents that
prevent germination with multiple nutrients by either: 1) blocking multiple receptors, 2)
Inhibiting an essential component in the signal transduction pathway between receptor
activation to DPA release, or 3) obstructing the DPA release itself. Amiloride, HgCl2,
octanoic acid, octanol, phenylmethylsulphonylfluoride, quinine, tetracaine, tosyl-Larginine methyl ester, and trifluoroperazine belong to this group. The other way of
preventing germination by nutrients is by analogues of the nutrient themselves
(analogues of germinants).
The current methods for preventing germination are grouped in the following
brackets according to their specific action:
A) Agents that block activation of the receptor (analogues of germinants)
Detailed in section 1.5.1.
B) Enzyme inhibitors
Protease inhibitors and sulphydryl reagents are able to stop nutrient
germination in several Bacillus species

(83, 86-88).

Sulphydryl groups present in

many enzymes involved in different steps of the spore germination. Most of
these groups are located in membrane components. Bacteriostatic agents that
can covalently modify sulphydryl can be considered germination inhibitors as
well (HgCl2, N-ethylmaleimide, cadmium acetate)
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(87).

Alkyl alcohols can

inactivate the lytic enzymes for the coat and cortex degradation

(89).

Other

enzyme inhibitors are calmodulin antagonists (trifluoroperazine). Inhibiting
calmodulin can stop spore germination of B. cereus and B. subtilis, therefore
this protein, triggered by Ca2+ as a second messenger, must be involved in the
signal transduction in the spore

(90).

C) Ion-channel blockers
Germination process requires water and cation transport as well as Ca2+-DPA
membrane translocators. Potential targets for inhibition are these membrane
proteins. Ion channel blockers, such as amiloride, were shown to disable the
germination in B. subtilis and B. megaterium

(60, 85).

Unsaturated long-chain

fatty acids have been tested with Clostridium sp., and may cause steric
disorganization or inhibit substrate transport by altering the proton gradient
and blocking the germination of the spores

(91).

Nisin and subtilin are natural

antibiotic peptides that also prevent germination in C. perfringens and Bacillus
anthracis

(92, 93).

The mechanism on how nisin acts in spores is not clear, but it

is correlated with a DPA release that can alter the dormancy of the spores. An
analogue effect can be obtained in C. difficile with Ramoplanin, an antibiotic
with nisin-like activity

(94).
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Table 3. Potential targets and agents that block germination of endospores
Ger receptor
blockers

Enzyme inhibitors

Ion-channel blockers

Agents acting by nonspecific mechanisms

6-thioguanosine

HgCl2§

Nisin‡

Phenols

D-alanine

N-methylmaleimide§

Subtilin‡

Sodium
hypophosphite

D-histidine

Cadmium acetate§

Ramoplanin‡

N-acetylmuramic acid

Tosyl-L-arginine
methyl ester†

Unsaturated longchain fatty acids‡

Alkyl alcohols

Leupeptine†

Amiloride**

Trifluoprezine*

Quinine**

Theophylline*

Tetracaine**

Potassium sorbate*

Procaine**

Sodium azide*
* Calmodulin antagonists
** Na+/K+ and Ca2+ channels blockers
§ Sulphydryl reagents
† Protease inhibitors
‡ Agents disrupting membrane permeabilty

1.5.1 Inhibition by Analogues of Germinants
Investigations done by several research groups (P. Hanna , C. Guidi-Rontani, and L.
Hornstra) have revealed the identity of different germination receptors in Bacillus
anthracis, as well as their agonist (germinants). Ligand binding is the basis of the
activation of the receptor and the initiation of the signaling pathways. Some molecules,
however, may bind the receptors without triggering their activation. These molecules
are known as ‘antigerminants’. They have similar structure to the nutrients that trigger
the germination but with modifications. Two types of germinants are found in B.
anthracis: nucleosides and amino acid molecules. Thus, antigerminants will be derived
either from a nucleoside, or from an amino acid. Antigerminants act as competitive
inhibitors with the germinants: they will interact with the Ger receptors competing
against the germinants for the binding site. The action of these molecules for preventing
germination relies on the affinity to the receptor: the higher the affinity, the lower the
concentration that is needed to bind the receptor and outweigh the germinant
activation.
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Figure 8. Representation of the two enantiomers of alanine

The first anti-germinant that was found to prevent germination was the enantiomer
of L-alanine: D-alanine (figure 8). D-alanine is not found in metazoans, but has been
isolated from certain bacteria supernatant. In 1964, D-alanine was found to be an autoinhibitor for the germination of B. globigii

(95).

Previous works from Halvorson (1954)

proposed a mechanism of germination auto-inhibition in bacteria by the enzyme alanine
racemase(96). H. Hu and colleagues demonstrated that D-alanine would hinder
germination of B. anthracis spores. Addition of D-alanine to the culture medium
resulted in a 75% inhibition of germination inside the macrophage cell line RAW 264.7.
After adding D-histidine, the effect was improved, preventing germination in a 100%.
They also showed that after adding L-alanine in higher concentrations than D-alanine,
they were able to reverse this effect and resume the germination of the spores

(97).

Subsequently, McKevitt and colleagues demonstrated that D-alanine also inhibits B.
anthracis germination in vitro. D-alanine was effective even at concentrations 10-fold
smaller than L-alanine (figure 8). M. McKevitt also found auto-inhibition by endogenous
racemase activity in these bacteria

(98).The

mechanism of this racemase for the

autoinhibition is not defined yet. The exosporium protein Alr has been associated with
the racemase activity. A mutant strain Δalr, defective in this gene, germinates more
efficiently in the presence of L-alanine than the regular Sterne strain
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(39).

Figure 9.

Studies of McKevitt et al. with D-Ala preventing spore
germination in vitro. After 30 minuntes, there is no significant
change in OD, after adding the highest concentration of D-Ala.
McKevitt, M.T., et al. Infect. Immun. (2007) 75: 5726-5734.

The second group of anti-germinants corresponds to the nucleoside derivates. Based
on the mutational analysis of Hanna there are four different pathways that cooperate
synergistically for the germination of B. anthracis
to

trigger

germination

by

itself

is

(68, 74).

L-alanine,

The only germinant that is able

but

at

un-physiologically

high

concentrations. After adding inosine, the most effective nucleoside germinant, the in
vitro spore germination is optimal. It has been shown that germination pathways in
both B. cereus and B. anthracis are synergic, so activating many pathways at the same
time show an enhancement of the germination. L-alanine at high concentrations (10
mM) activates only one pathway via GerL/GerK. However, L-Ala and inosine together
activate also the AAID-1 pathways, involving the two alternate set of receptors
GerS/GerH/GerL and GerS/GerH/GerK. A nucleoside anti-germinant will block at least
the three different pathways in which GerH is involved (see figure 7).
Abel-Santos and colleagues demonstrated the effect of different nucleoside
analogues that inhibit the spore germination in vitro with B. anthracis Sterne strain.
The analogues were screened from a large library of compounds derived from two
germinants: inosine and guanosine. From this large number of analogues, only few
compounds inhibited the germination in vitro. All the inhibitors have in common a
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substitution in the position 6 of the purine base (derived from 6-thioinosine, 6-TI), or
substitution at positions 2 and 6 (derived from 6-thioguanosine, 6-TG). The highest Ki
corresponded to 6-methylmercaptopurine (6-MMPR) (table 4). Those that were able to
inhibit the process of germination in vitro also were tested in macrophages RAW 264.7,
but only 6-thioguanosine (6-TG) was able to protect the mammalian cells from B.
anthracis killing

Table 4.

(99).

Nucleoside analogues that inhibited B. anthracis germination in vitro.
Their corresponding inhibitions are also shown below. Akoachere,
M. et al (2007) J. Biol. Chem. 282: 12112-12118
N
HO

O
HO

N

X
N
N

Y

OH

Substrate
Inosine
6-thioinosine (6-TI)
6-methylmercaptopurine riboside (6-MMPR)
6-thioguanosine (6-TG)
6-O-methylguanosine (6-OMG)
6-chloroguanosine (6-CG)
6-aminoguanosine (6-AG or 2-AA)
Xanthosine

X

Y

OH
SH
SCH3
SH
OCH3
Cl
NH2
OH

H
H
H
NH2
NH2
NH2
NH2
OH

Ki (μM)
Germinant
(Km = 270 μM)
N/I
31
98
34
87
68
777

The hypothesis made by Abel-Santos group is that the inhibitors are not actually
anti-germinants, but very slow germinants, with a drastically lower efficiency than
inosine. They have shown that 6-TG has a longer lasting effect than 6-MMPR in terms
of OD decrease, even though that 6-MMPR has higher affinity than 6-TG (figure 10).
However, even with 6-TG, there was a residual background of dead cells due to the
ability of 6-TG to work as a very slow germinant.
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Figure 10. Effect on the B. anthracis germination inhibition in vitro by
6-TG and 6-MMPR (obtained by Abel-Santos et al). Both
compounds acted as slow germinants in comparison with
inosine, but 6-TG rate was considerably slower than 6MMPR. Akoachere, M. et al (2007) J. Biol. Chem. 282:
12112-12118.

1.5.2 Protection of Macrophages by Antigerminants
Inhibiting the germination is a promising strategy for anthrax prophylaxis.
Unfortunately the research done in vivo has not been as successful as expected. The low
permeability of the spore membranes is one of the facts that may impede the use of
anti-germinants as a potential target. Nevertheless, spores need to be sensitive to
germination stimuli. It was mentioned on sub-chapter 1.4.1 that B. subtilis gene gerP
was associated with a protein that is likely to enhance the diffusion of germinants
through the outer layers of the spore. Besides the permeability of the spore there is
another hindrance: changing from in vitro to in vivo conditions. What happens inside
the cell is completely different to that in controlled conditions. The most notable aspect
is the multiple combinations of nutrients present in the phagosome that may act as
germinants. The different pH, ions, peptides and enzymes present in the cell can alter
the kinetics of the process.
One of the promising aspects of the antigermination therapies is that they block a
crucial step for the anthrax infection. It might be the best short-term prophylaxis, in
combination with antibiotics to prevent the outbreak after inhaling or ingesting spores.
Nowadays,

there

are

only

two

efficient
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anti-germinants

that

protect

murine

macrophages from B. anthracis mediated killing: D-Ala and 6-TG. Attempts for stopping
the disease in mice have been unsuccessful so far.
At least one germination receptor is fully required for the germination of B. anthracis
inside the macrophages: GerH

(100).

Plasmid receptor GerX, located in virulence plasmid

pOX1 can improve this germination significantly

(69).

It has been demonstrated that

spores that are not able to germinate efficiently (ΔgerH) lose their viability and are killed
inside the phagolysosome of macrophages RAW 264.7
outside the phagolysosome are also readily killed

(97).

(101).

Spore that pre-germinate

These experiments illustrate the

importance of an optimal germination, with the contribution of all germination
receptors, for the spore survival inside the macrophages. The rapid maturation of the
bacteria, the synthesis of toxins, and the expression of the atxA-activated membrane
damaging agent are crucial to outdo the action of the phagolysosome.
H. Hu and colleagues have used a combination of two antigerminants to provide full
protection to macrophages. The relevance of GerH for germination is a reason to
consider this receptor as an important antigerminant target. This research group
revealed that combining D-alanine and D-histidine blocks the main pathways for
germination of B. anthracis (Alanine, AAID-1, AAID-2) resulting in 100% survival of the
macrophages and the subsequent inactivation and killing of the spores by the
phagosome

(97, 101).

On the other hand, nucleoside anti-germinants are being studied by E. Abel-Santos
and colleagues for the potential protection of macrophages. Previous work has shown
that 6-thioguanosine (6-TG) gives almost 100% of protection after six hours of infection.
Fluorescence microscopy revealed that cells infected with B. anthracis Sterne strain
were killed starting at 3 hours, whereas cells treated with 6-TG were viable, even after 7
hours (figure 11). Interestingly, concentrations of 6-TG required for protection of
macrophages were 100-fold smaller than those for inhibiting germination in vitro

(99).

Further research is being conducted by this group with a broader spectrum of
analogues for screening.
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Figure 11. Prevention of cell killing mediated by B. anthracis spores by 6-TG, revealed
by fluorescence microscopy. Cells were stain with Syto-13 (Green) and
propidium iodide (Red). The last one is impermeable to membrane, and
may only stain by binding to DNA from necrotic or apoptotic cells. These
figures obtained by Abel-Santos et al illustrate that RAW 264.7
macrophages treated with remained viable after 7 hours, whereas nontreated macrophages were being killed within 3 and half hours. Akoachere,
M. et al (2007) J. Biol. Chem. 282: 12112-12118.

1.6 Hypothesis and Research Questions
The recent findings suggest that nucleosides in combination with an amino acid
are essential to trigger the germination of B. anthracis endospores

(68, 74).

These

compounds bind and activate protein receptors located in the inner membrane of the
spore

(54).

Among the nucleosides, inosine is the best germinant

(74, 99).

6-Thioguanosine

(6-TG) is a nucleoside analogue that protects macrophages from killing by its antigerminant effect on the spores
germination in vivo

(97),

(99).

Since the nucleoside receptor GerH is necessary for

we hypothesize that inosine analogues derived from 6-TG that

interfere with the binding of nucleosides to the receptors will prevent germination of the
spores and protect macrophages from an imminent necrosis mediated by the bacterial
toxins.
The parameters for the efficacy of a good nucleoside anti-germinant were one of
the matters of concern in the present study. The chemical and functional identity of
the substituent that enhances the inhibitory properties of the compounds needed to be
determined: certain chemical groups, substituting specific positions on the molecule,
may interfere with the germination; some of them will not show any effect; while others
could even act triggering the germination.
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Another intriguing aspect of this research was answering why some antigerminants are efficient in vitro, but they are not able to inhibit germination inside the
macrophages. Binding affinity, defined by the inhibition constant (Ki), would not
necessarily correlate with the efficacy in protecting cells. In addition, that binding
affinity obtained in vitro can be different than the one of inside mammalian cells. Some
molecules are not permeable to cell membranes, but even if they are permeable they
must penetrate the thick outer layers of the spore and reach the inner membrane,
where the receptors are. There are many more aspects that vary from a buffer to cells:
acid pH, oxidative agents, enzymes, and many more nutrients that are competing with
the anti-germinant.
Finally, it was necessary to clarify a possible interaction of two anti-germinants of
different class, each one interacting with a different receptor. Previous work showed
that there are four different germination pathways that can be activated in B. anthracis.
The activation of two or more pathways together has a cooperative effect for the
germination of the spore. Correspondingly, the addition of a combination of two antigerminants targeting two different pathways must enhance the inhibitory effect.

1.7 Specific Aims of the Study
Based on the potential benefit that anti-germinants may represent as a novel
target for anthrax prophylaxis, our study focused on the screening of an array of 43
different compounds derived from 6-thioguanosine (6-TG), one of the drugs that
prevented cell killing by B. anthracis. The present work allowed the identification of
different purine nucleoside derivatives that prevent the germination in macrophages.
For each inhibitor, their respective half-maximal inhibitory concentration (IC50) was
obtained. These results were corroborated and compared by testing the rate of
germination in vitro.
The effect on the germination by the different analogues was observed directly,
through phase contrast and fluorescence microscopy, and measured by cell viability
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assays. The data was obtained in intervals of thirty minutes to be able to see the
process of inhibition through time. The results obtained contributed to the
understanding on the kinetics of the spore mediated killing.
By analyzing structure activity relationships of these inhibitors it was possible to
identify the parts of the molecule that are implicated with the receptor binding, and the
nature of those chemical substitutes that interfere with the receptor activation.
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CHAPTER 2
MATERIAL AND METHODOLOGY
2.1 Bacterial Strain and Growth
The bacterial strain used for the present studies was Bacillus anthracis ΔSterne
34F2. The strain was provided by Dr. Arturo Casadevall from the Albert Einstein College
of Medicine, NY. These bacteria carry one of the plasmids of virulence pXO1, but lacks
pXO2, for the synthesis of the poly-D-glutamic acid capsule. Plasmid pXO1 contains the
genes for the expression of the three major toxins: PA (protective antigen), EF
(calmodulin-dependent andenylate cyclase), and LF (Zn-metalloprotease). It also
contains the gene for the germination operon gerX. Thus, the strain carries all the
possible germination operons that have been identified (table 2).
The lack of capsule makes the vegetative bacteria vulnerable to the immune system
response, with a subsequent killing led by macrophages, making this strain nonpathogenic to mammals. It is therefore considered a non-virulent, but toxigenic strain
requiring a bio-safety level 2 for its shipping, manipulation, and use. Table 5 shows a
comparison of the differences between the strain that is used and the pathogenic Ames
Florida that was used for the 2001 attacks. For the latter one, its use is authorized only
in certain institutions in the USA under BSL-3

(6).

The bacteria can be grown in aerobic conditions, in Luria-Bertani (LB) broth. The
initial culture may be obtained by inoculating spores or from a frozen stock. The
optimal growth is achieved at 37°C (mesophilic micro-organism). From this initial
culture in LB broth, sub-cultures can be done in solid media, such as nutrient agar.
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Table 5. Differences between Sterne and the virulent Ames strain
of Bacillus anthracis.
Sterne 34F2

Ames Florida
(A2012)

pOX1+/pOX2-

pOX1+/pOX2+

Capsule of poly-γ-D-glutamic acid

No

Yes

Expression of toxins (PA, EF, LF)

Yes

Yes

Toxin-mediated necrosis of macrophages

Yes

Yes

Pathogenesis and proliferation inside the
host organism

†

No

Yes

Penicillin resistant

Yes

Yes

AVA vaccine resistant

No

Yes

Properties
Virulence Plasmids

†

There can be some exceptions of Sterne-related infections when patients
are immuno-compromised or spores that make contact with a pre-existing
wound. It is unlikely to acquire infection through oral or inhalational route.
No human disease due to the Sterne strain has been reported (6).
2.2 Spore Preparation
For sporulation, the bacteria were incubated at 37°C for 5-7 days in a modified
nutrient agar medium, containing the following minerals: KCl (0.1%), MgSO4 (0.012%),
Ca(NO3)2 (1 mM), MnCl2 (0.1 μM), FeSO4 (1 nM). The pH of the medium was adjusted to
7.6. Sporulation was confirmed through Schaeffer-Fulton8 staining, before harvesting.
Plates were harvested by suspension of cells in double-distilled ice-cold water
(ddH2O). After three washing steps, endospores were separated through centrifugation
by density using HistodenzTM (Sigma-Aldrich) at a 20 to 50% gradient (figure 12).
The spore pellet must be resuspended in ddH20, and washed five more times, in
order to remove cellular remnants and get a better degree of purity in the spores. After
washing, spores were stored in aliquots of 0.5 mL, and kept at 4°C.

8Schaeffer-Fulton

spore stain – A differential staining technique that uses malachite green (50
g/L) to stain spores, and a counter-stain of safranin or safarin (5 g/L) for vegetative cells
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20%
Vegetative
bacteria
50%
Spore
pellet

Figure 12. Fractions obtained after centrifugation with Histodenz. Vegetative
bacteria remain at the inter-phase of the two densities, whereas
spores precipitate, forming a thick pellet.

2.3 Analysis of the Spore Germination In Vitro.
The first step that must be done in any study of spore germination, before using the
spores, is the heat activation at 70°C for 30 minutes. This heat activation has a dual
purpose: 1) killing the non-sporulating organisms or vegetative cells that may be
present in the sample and 2) heat-shocking the spores to enhance the predisposition of
spores for germination. Sub-lethal heat seems to increase the ability of the spore to
germinate

(32).

The molecular basis of the heat-activation remains unknown.

Following the heat-activations, spores are washed, and resuspended in germination
buffer (50 mM Tris-HCl; 10 mM NaCl; pH 7.5). This buffer provides the optimal pH and
salt concentration for the germination of B. anthracis endospores. Spores are diluted in
germination buffer in order to get an optical density of 1.00 (equivalent to a
concentration of 108 spores/mL).
The germination of the spores is monitored by a decrease in optical density. The
previous chapter addresses the property of ‘whitening or refractivity’ of the endospores
given by the coat proteins. This property distinguishes spores from vegetative cells and
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can be monitored with the absorption of light at 580 nm. The absorbance was registered
by Biomate 5 spectrophotometer from ThermoSpectronics®.
In some cases minimal amounts of nutrients coming from cellular debris traces,
may act as germinants, triggering the spore germination. A control must be run to see if
there is no auto-germination: monitoring a decrease in OD580 for 15 minutes and
variation should be less than ±0.05. If fluctuations exceed this interval, there is an
auto-germination background that may affect the further studies.
After ensuring that no auto-germination is present, it must be confirmed that spores
are able to germinate when germinants are added. For this purpose B. anthracis
germination requires one nucleoside analogue and an amino acid acting as cogerminants. In the present studies we have used inosine at 0.25 mM and alanine at
0.04 mM to the spore suspension in germination buffer, in order to activate the spore
germination in vitro.

Healthy spores were able to germinate almost fully within the

range of 15 minutes (figure 13). Germination is complete when it reaches the minimum
possible optical density of the suspension, in the range of 0.45 to 0.48.

Germination in vitro of B. anthracis endospores
1.1
1

Control

Relative OD

0.9

Ino (0.25 mM)
+ Ala (0.04
mM)]

0.8
0.7
0.6
0.5
0.4
0

5

10

15

20

25

30

Time (Minutes)
Figure 13. Decrease in optical density observed after adding inosine
(Ino) and L-alanine (Ala) to the spore suspension.
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The actual OD obtained is transformed to relative OD; a magnitude defined by the
OD obtained at time 0 divided by the OD read at certain time. Relative OD is a measure
that allows a better comparison between two different data sets, since the initial OD
may vary considerably from one experiment to another.
For the analysis of nucleoside analogues on the germination in vitro, a kinetic assay
was performed using Greiner Bio-one® flat transparent 96-well plates. Each well was
filied up to a final volume of 0.2 mL of spore suspension. Nucleoside analogues were
added from stock solutions to the desired concentration in volumes not higher than
10 μL. Analogues were incubated in the suspension at room temperature for 15
minutes. Subsequently, germinants (inosine and alanine) were added. Data was taken
each minute for 45 to 60 minutes. To ensure accuracy in the results, samples were
repeated in triplicates. Readings were done by the multi-well plate reader Tecan Infinite
M200®. Germination was confirmed by light microscopy using the Schaeffer-Fulton
endospore staining technique (figures 25 and 75).

2.4 Cell Line
The mammalian cell line used in the further studies is the J774a.1 murine
monocyte/macrophages. The cell line was a gift from Dr. Jürgen Brojatsch, at the Albert
Einstein College of Medicine, NY. The cell line is originated in the Mus musculus strain
BALB/cN, from a reticulum cell sarcoma. The properties of this cell line (IL-1β
production, complement receptor, and IgG receptor) enhance the antibody-dependent
phagocytosis of the macrophages

(102).

The endospore intake is therefore efficient in this

cell line.
Initially we tested the cell line RAW 264.7, also murine macrophages. However the
spore intake by RAW 264.7 was not as efficient as in J774a.1; thus, the germination
process was slower and the amount of spores required in terms of multiplicity of
infection (m.o.i.) was higher.

47

Figure 14. Photography at phase contrast microscopy of the cell line J774a.1

2.5 Medium and Growth Conditions for Mammalian Cells
For culturing the cell line J774a.1, the medium used was the Dulbecco Modified
Eagle’s medium (DMEM) without L-glutamine, obtained from Cellgro® Mediatech Inc.
The medium was supplemented with 10% of dialyzed fetal bovine serum from
HyClone®, GlutaMAXTM

9

from InvitrogenTM, penicillin (100 IU/mL), and streptomycin

(100 μg/mL). The last two were obtained from Cellgro®.
Cells are incubated in tissue culture treated Petri dishes of 10 cm of diameter. The
volume of media added to each plate was 10 mL. Plates are stored in an incubator, at
37°C, and a humidified atmosphere with 5% CO2.
When cells reached a confluence10 from 80-90%, sub-culturing is required for the
continuity of the cell line from the primary culture. For sub-culturing, cells are
detached from the plate using phosphate buffered saline solution (PBS) without calcium
and magnesium (Cellgro®), supplemented with 5mM of EDTA. Cells are counted using a
9

GlutaMAX is a substitute of L-glutamine that does not degrade in cell culture, and does not form
ammonia as a byproduct. It improves cell viability and growth, and delays the phase of
senescence in the cells (103).
10

Confluence refers to the extension of the cell monolayer on the plate. A confluence of 100% is reached
when the monolayer covers the full area of the plate. After confluence reaches 90%, macrophages J774a.1
stop the exponential growth, entering the plateau phase.
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hemocytometer. The cell suspension is centrifuged and resuspended in fresh medium.
Sub-cultures are seeded to a final concentration between 50,000-100,000 cells/mL. The
following sub-culture takes places within the next 4 to 5 days. After the 8th subculture,
the health of the cell line decays, so a new primary culture is required directly from the
frozen stock. Frozen stocks must be kept in liquid nitrogen at -180°C.

2.6 Nucleoside Analogues
The different nucleoside analogues tested in the present study were purchased
either from Sigma-Aldrich Corporation (Saint Louis, MO) or from Berry & Associates
(Brea, CA); or synthesized by Dr.Kyungae Lee from the National Screening Laboratory in
Biodefense (NSRB). The analogues used are grouped in three categories according to
their structure: a) nucleoside analogues derived from inosine and guanosine, b) purine
bases derived from the nucleoside analogues, and c) analogues containing only the sixmember heterocyclic ring of the purine. The list of analogues is given in tables 6, 7, and
8.
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Table 6. Nucleoside analogues derived from inosine and guanosine

6-thioguanosine
(6-TG)

6-benzylthioinosine
(6-BTI)

†

8-hydroxyguanosine
(8-HG)

7-methylinosine
(7-MI)

†

6-chloroguanosine
(6-CG)

6-thioinosine
(6-TI)

Allopurinol riboside
(APR)

6-methylmercaptopurine
riboside
(6-MMPR)

N6-cyclohexyladenosine
(CHA)

Immucillin H
(IH)

Xanthosine
(X)

6-chloropurine riboside
(6-CPR)

6-O-methylguanosine
(6-OMG)

Nebularine
(Neb)

1-(4-(9-(β)ribofuranosyl)-9H-purin6-yl)piperazin-1yl)ethanone †
(PPER)

6-Nbenzylmethyladenosine
(BMA)

†

Compound synthesized by Dr. Kyungae Lee from the NSRB.
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Table 6. (Coninued from page 50)

N6,N6-dipropyladenosine†
(6-DPA)

Isoguanosine
(IG)

6-N-((3-ethylacetyl)cyclohexyl)
adenosine †
(6-ECA)

†

6-(γ,γ-dimethylallyl
amino)purine riboside
(6-DMAA)

Tubercidin
(Tu)

6-N-dimethyladenosine
(6-DMA)

2-aminoadenosine
(2-AA)

8-aminoadenosine
(8-AA)

Compound synthesized by Dr. Kyungae Lee from the NSRB.
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6-methylaminopurine
riboside
(6-MAPR)

†

2-aminopurine
riboside
(2-APR)

6-N-benzoyladenosine
(6-NBA)

Table 7. Purine bases derived from nucleoside analogues

6-chloroguanine
(6-Cg)

6-thioguanine
(6-Tg)

6-N-benzylaminopurine
(6-BAP)

Allopurinol
(Ap)

6-mercaptopurine
(6-Mp)

6-cyanopurine
(6-CyP)

2-mercaptobenzimidazole
(2-MBI)

2-methylmercaptobenzimidazole
(2-MMBI)

Table 8. Analogues containing the six-member ring from the purine and other
analogues of non-specific category.

2-mercaptopyrimidine
(2-MPm)

2-thiouracil
(2-TU)

Trithiocyanuric acid
(TTCA)

2,4-diamino-6mercaptopyrimidine
(DAMPm)

2-mercaptopyridine
(2-MPy)

4-mercaptopyridine
(4-MPy)

Gancyclovir
(GCv)

β-mercaptoethanol
(BME)
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2.7 Spore Killing Assay
The purpose of these assays is to assess the effect of the analogues in protecting
macrophages from necrosis. The cell line J774a.1 will be treated with the respective
compounds and then infected with endospores of B. anthracis. Cell necrosis is
correlated with the germination of the spores inside the macrophages, and the
production of the membrane-damaging toxins EF and LF. The more cell viability is
observed, the better the protective effect of the anti-germinant has been. Cell viability
will be monitored by direct observation through phase-contrast and fluorescent
microscopies, and by quantification of fluorescence emission (sub-chapter 2.9).
Cells will be harvested after the culture reaches a confluence of 80-90% (beginning
of the lag phase). For this assay is important to ensure that at least 95% of the cells are
viable. Otherwise, the background of dead cells may affect the results. For this reason is
important to count by direct observation through the hemocytometer, counting both
viable and non-viable cells (Trypan-blue positive11). If the percentage of non-viable cells
is above 5%, is recommendable not to perform the assay with these cells. In order to get
a good percentage of cell viability, cells must be harvested just before reaching the
maximum confluence (a considerable amount of cells enter senescence during lag
phase), washed at least two times with PBS to remove floating dead cells; and detached
with the least harsh methods (pipetting up and down the suspension instead of cellscraping).
After counting, cells will be centrifuged and resuspended in new medium to a final
concentration of 1 x 106 cells/mL. The medium used for this assay, must not contain
antibiotics (streptomycin and penicillin), and must be free of any serum. Serum may
induce germination outside the macrophages. The cell suspension is added in volumes
of 80 μL to each well in a Greiner Bio-one® 96-well plate. Samples are repeated in
triplicates. After incubating for 1 hour at 37°C and 5% CO2, the corresponding
Trypan blue is a stain used for animal cells, that selectively colours dead cells blue, while the
living cells remain uncolored.

11
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treatment is added to cells in volumes of 10 μL. Cells are now incubated for 30 minutes
with the treatment. Subsequently spores are added in volumes of 10 μL, to get an m.o.i.
of 5. The final volume of sample in each well should be 100 μL.
80 minutes after the inoculation of the spores, cells are washed two times with
Hanks balanced saline solution (HBSS). After washing each sample is replaced with new
medium containing the corresponding treatment. The purpose of this wash is to remove
the majority of spores that were not taken by the macrophages. Such spores may
germinate in time, giving a background of extracellular germination, and affecting the
accuracy of the assay. After washing, the plate must be put inside the incubator again,
until the time for measurements comes. Normally data acquisition starts at 3 hours
after infection, which is the time when cell necrosis begins.

2.8 Direct Quantification of Cell Viability
Measuring the amount of living cells can be done by several techniques. Nowadays,
the most efficient methods for quantification of cell viability are based on fluorescent or
luminescent dyes. Our method of quantification is based on the fluorescence emission
of propidium iodide (PI), which stains specifically necrotic cells. (See sub-chapter 2.9).
In order to assess the accuracy of the fluorescence quantification, we have performed
cell counts by direct observation at phase contrast microscopy.
The first step for counting is selecting a specific range of the field of vision. The field
of view is based on observation at 40X lens. The area of field must have a number of 30
to 50 cells, to be representative statistically. In our case, we have selected to count 1/16
of field of view at 40X (figure 15). We count three random areas for each sample to get
data in triplicates.

54

Figure 15. Range selected for counting at 40X field (highlighted in gray).

To distinguish necrotic from living cells the methodology performed is based on
counting nuclei. Necrotic cells have a nucleus with a disrupted membrane. Membrane
integrity can be observed through bi-refringence12. Cells that show bi-refringence are
considered viable (figures 14 and 16).

Healthy
Macrophages

Macrophages with
phagosome containing
endospores

Necrotic
Macrophages

Figure 16. Photography of the different cellular stages of macrophages
after infection with spores.

Counts have been done hourly after infecting with B. anthracis endospores. The
data obtained after counting is transformed to percentages of dead cells vs. living cells.
Results are shown in the next chapter.

Bi-refringence or double-refraction is the property of deviate an incident ray of light into two
polarized rays, perpendicular to each other. This can be observed in cell membranes at phase
contrast microscopy; in an specific focus of the lens the membranes appear to be particularly
bright.

12
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2.9 Fluorescence Quantification of Cell Viability
For assessing the cytopathic effects after performing the spore killing assay the
method that was chosen was by fluorescent staining with propidium iodide (PI)

(104).

Propidium iodide is an intercalating agent and a fluorescent molecule. It binds DNA by
intercalating between the bases. Once is bound to nucleic acid its fluorescence is
enhanced by near 30-fold. PI is impermeable to cell membranes and may not reach the
nuclear material in viable cells. Thus, the fluorescent stain is specific only for necrotic
or apoptotic cells with damaged membranes. When bound to DNA, PI can be excited at
a maximum of 535 nm wavelength, emitting at the peak wavelength of 617 nm.

Figure 17. Molecular structure of propidium iodide.

A 10X solution of PI was prepared by dissolving the compound in phosphatebuffered saline solution. Just before taking the read-outs, PI was added to each well to
a final concentration of 20 μM. The 96-well plate was shaken at dark for 10 minutes.
Subsequently, readings were done in a TECANTM Infinite® M200 cuvette/multi-well
plate reader (with monochromator). After the respective data was acquired, the plate
was put to the incubator again (37°C at 5% CO2) until the next reading. Readings were
normally taken every 30 minutes within 3 to 7 hours after infecting macrophages with
the endospores. The obtained data in fluorescence units, was transformed into relative
intensity. Relative intensity (RI) is magnitude used for standardizing all read-outs, since
the background fluorescence may vary from one experiment to another. RI is defined as:
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RI =

FUx – FUc

FUc

FUx is the specific value of each well, measured in fluorescence units, and FUc is the
lowest possible value of the control (viable cells free of spores) or “zero value”. By using
RI it is possible to remove the residual fluorescence values and see the specific increase
of dead cells in each well.

2.10 Fluorescence Microscopy
A direct observation on the cytopathic effect of was done by using the microscope
Olympus BX51. J774a.1 cells were seeded to Lab-Tek® glass chambered cover slides.
The cell killing assay was performed with the same procedure as in sub-chapter 2.7,
but with a final volume of 500 μL of cell suspension in each chamber of the microscopy
slide. Each slide carries four chambers. One chamber was the control of cells free of
spores, the second had the infected cells without any treatment, and the remaining two
were used to see the effect of two different treatments on cells: 6-thioguanosine and 6thioguanine.
Two repeated slides were incubated, for two observations at 3 and 6 hours after
infection. Before observing at the microscope, cell media was removed from each
chamber, and cells were stained with PI at 20 μM concentration, and DAPI

13

(4',6-

diamidino-2-phenylindole) at a 5 μM concentration. The latter one is used as a counterstain for viable cells.

DAPI is a commonly used dye in fluorescent microscopy. It binds DNA absorbing wavelength at
a maximum 358 nm, and the maximum of emission is at 461 nm. It is permeable to cell
membranes, staining either viable or non-viable cells.

13
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2.11 Half-maximal Inhibitory Concentration of the
Protective Effect in Cells
An IC50 was obtained for each of the nucleosides that showed a protective effect in
the first screening. A spore killing assay was performed as is shown in sub-chapter 2.7,
by adding the nucleoside analogues at varying concentrations (0.1, 0.5, 1, 5, 10, 50,
100, and 500 μM). Cell viability was measured by fluorescence readings after staining
with PI (sub-chapter 2.9). The first reading was taken approximately 3.5 to 4 hours after
infecting; time when necrotic cells start to appear. Successive readings were taken every
30 minutes until 6 to 6.5 hours. All of assays were carried out in triplicates.
An arbitrary time point was selected before reaching saturation14. Values given in RI
were used for plotting against the decimal logarithm (log) of the concentrations. The
data in semi-log plots was fitted into a non-linear regression of four-parameter logistic
curve, using the software SigmaPlot v.11. The IC50 were automatically obtained by the
regression analysis performed by the software. All the R squared (R2)15 values given for
the different regressions were over 0.9.

2.12 Half-maximal Inhibitory Concentration of the
Germination Inhibition in vitro
Assays of germination in vitro were performed in order to corroborate the results of
the protective effect on cells: blocking pathogenesis on cells is directly related with
inhibiting the germination of the spores in vitro. For obtaining IC50 of the inhibition in
vitro, purified spores were diluted in germination buffer, and incubated with the
nucleoside analogues for 15 minutes. The concentration selected for the analogues was

At a given time, usually after 6 hours of infection, all cells will eventually become necrotic. The
protective effect of the anti-germinant slows down the kinetic of the germination but does not stop
it.
15 R2 is the square of the Pearson’s correlation coefficient r, which is a statistical index that
determines correlation between the data and the equation that fits the regression. “r” is defined
by the quotient of the covariance of the two variables divided by the covariance of each dependent
and independent variable for separate. R2 has values between 0 and 1, being 1 the optimal fit for
the regression.
14
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in a range between 5 μM to 10 mM. All samples were repeated in triplicates.
Germination was monitored using the TECANTM Infinite® M200, reading absorbance at
580 nm, each minute for 45 minutes. An arbitrary time point was selected. Values of
relative OD were plotted against the decimal logarithm of the respective concentrations.
The data was fitted into a non-linear regression of four-parameter sigmoidal curve,
using SigmaPlot v.11. The half-maximal inhibitory concentrations (IC50) were given in
the regression analysis. All R2 values obtained were above 0.9.
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CHAPTER 3
RESULTS
3.1 Protection of J774a.1 by 6-thioguanosine from B. anthracis
Mediated Necrosis
To validate effectiveness of 6-TG on previous works done by Akoachere et al (2006)
(99),

studies on macrophages and in vitro were carried out. The first assessment was

through direct observation of the necrosis by using phase contrast microscopy.
Subsequently cell viability was measured by quantification of PI fluorescence emission,
and observed through fluorescence microscopy. With these results we show that 6-TG
efficiently protects the macrophage cell line J774a.1 from killing by B. anthracis.
3.1.1 Direct Counting
A cell killing assay was performed following the methods stated in sub-chapter 2.7,
with the exception that there was no wash with HBSS at 80 minutes. For this assay,
cells were treated with three different concentrations of 6-TG : 1, 10, and 100 μM. Cells
were counted hourly 1-6 hours after infecting with the spores. Both viable and necrotic
cells were counted in three different fields, and the average percentage of each was
obtained. Only the highest concentration of 6-TG was showed a significant protection
on the cells after six hours (figure 18).
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Figure 18. Percentage of necrotic cells after infecting with B. anthracis. J774a.1 cells were
infected with B. anthracis endospores at an m.o.i. of 10. Necrosis started to be
visible within the 1-2 hours after infecting cells. Cells that were uninfected (control)
showed almost 100% viability throughout the whole experiment. 6-TG protected
cells from necrosis at concentrations of 10 and 100 μM within the range of 2-4
hours. After 5 hours only the highest concentration showed full protection.

3.1.2 Quantification by Fluorescence
Another assay like in the previous sub-chapter was performed, but this time cell
necrosis was monitored by the propidium iodide exclusion assay (sub-chapter 2.9).
Results were similar to those obtained by direct cell counting (figure 19).
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Figure 19. Fluorescent quantification on J774a.1 cell killing with B. anthracis at 6
hours. Necrosis was monitored by PI-DNA fluorescence. The highest
concentration of 6-TG was the only to show protection after 6 hours.
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In the previous figure we have shown that the PI-DNA fluorescence detection
correlates with direct counting results; thus, it is an accurate procedure for measuring
the amount of cell killing, and the method may be used in the further experiments.
After infecting our cell line, observations through phase contrast microscopy show
considerable amount of spores germinating in the medium, before they undergo
endocytosis by macrophages. After 75 minutes of infection, many spores have been
already phagocyted by the macrophages. By performing a washing step at 80 minutes it
was possible to remove many of the spores that are floating outside the cells. This
washing step is crucial for getting a more specific response for the effect of the antigerminant, since spore germination in vivo occurs within the macrophages. Figure 20
shows that protective effect by the anti-germinant was increased by performing a wash
at 80 minutes.

Effect of washing medium at 80 minutes
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Figure 20. Fluorescent quantification on J774a.1 cell killing with B. anthracis. Protective
effect of 6-thioguanosine is increased, by removing spores that germinate outside
the cells. Readings were taken at 6 hours after infection. Samples that were not
washed showed a necrosis rate near 1-fold higher.
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These previous experiments were performed using TECAN GENiosTM microplate
reader. The machine does not have monochromator and detects fluorescence by
irradiating and absorbing with filters for specific wavelengths. The filters available were
530 nm for excitation and 590 nm for absorbance. For propidium iodide the peak in
emission is at 617 nm, so the signal registered from PI-DNA fluorescence is not the
optimal. In the further experiments we have changed the reader for the one that is
mention in chapter 2 (TECANTM Infinite M200). By using this reader, that is equipped
with monochromator, the emission was detected at is maximum wavelength (617 nm),
and signal from PI-DNA fluorescence was enhanced. In figure 21, the signal coming
from necrotic cells is increased to near a 3-fold of intensity, in comparison with
previous graphs, where the increase is approximately 1-fold.
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Figure 21. Protection by 6-TG at 4 and 6 hours. After removing spores at 80 minutes,
protective effect by the nucleoside was enhanced, even at 1 μM. Signal was
optimized by performing readings with the TECANTM Infinite M200 with

monochromator.
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3.1.3 Fluorescence Microscopy
The protective effect by 6-TG was also observed by fluorescence microscopy.
Observations at the microscope were used as qualitative assessment to corroborate the
results obtained by the previous quantitative methodology. Propidium iodide was the
exclusive stain for necrotic cells, whereas DAPI was used as counter-stain. The number
of PI positive cells increased considerably in non-treated cells after 6 hours. (figures 22
and 23).

A

B

C

Figure 22. Microscopy observation at 3 hours. The three upper images correspond to phase
contrast microscopy, and the bottom images to the respective fields with fluorescence
microscopy. PI positive cells are bright-reddish, and the remaining cells stained with
DAPI are blue. ‘A’ belongs to the control of non-infected macrophages; some residual
background of non-viable cells is observed. ‘B’ shows the infected non-treated cells;
the amount of necrotic cells is similar as in the control, since toxin-mediated killing
has barely started. ‘C’ correspond to the cells treated with 10 μM 6-TG. The upper
pictures B and C illustrate an efficient spore uptake by the J774a.1 cells.
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Figure 23. Effect of 6-TG after 6 hours. The upper images correspond to phase contrast
microscopy, and the bottom images to the respective fields with fluorescence
microscopy. PI positive cells are reddish, and the remaining cells stained with DAPI
are blue. ‘A’ belongs to the control of non-infected macrophages. ‘B’ shows the
infected non-treated cells. A complete necrosis of these cells can be shown in both
phase contrast and fluorescence microscopy (all cells are PI positive). Arrows indicate
the outgrowing vegetative bacilli. ‘C’ belongs to the cells treated with μM 6-TG. The
fluorescence microscopy picture shows a near complete protection of these cells from
necrosis. Spores that were phagocytosized by J774a.1 did not germinate with the
treatment at 6 hours (upper C picture).

3.1.4 Analysis of the Spore Germination In Vitro
An assessment for the effect of 6-TG in preventing spore germination was performed
in vitro following the procedure in sub-chapter 2.3. 6-thioguanosine was added in
combination with the germinants. Approximately a 25% of the spores treated with 6-TG
germinated, in contrast with the spores with the germinants only. Figure 24 shows that
6-thioguanosine affected considerably the kinetics of B. anthracis germination,
confirming the results obtained by M. Akoachere et al
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(99).
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Figure 24. Effect of 6-TG on endospore germination in vitro. L-alanine (0.04 mM) and
inosine (0.25 mM) triggered the germination of most of the spores within 5
minutes. When 6-TG (1 mM) was added the velocity of the germination
decreased considerably, confirming that inhibits spore germination.

An

observation

through

light

microscopy

was

performed

as

a

qualitative

assessment. Spores were added to LB broth and incubated at 37°C in agitation. The
Schaeffer-Fulton selective spore staining was applied to observe the germination at the
microscope. Most the 6-TG-free spores germinated and matured after incubating 40
minutes. Treating spores with 6-TG did not stop germination in vitro, but slowed it
down. At 40 minutes, the many treated spores showed an incomplete germination, and
many did not even start germinating (figure 25).
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Broth – 5 minutes

Broth – 40 minutes

6-Thioguanosine – 15 minutes

6-Thioguanosine – 40 minutes

Figure 25. B. anthracis endospore germination observed at light microscopy (100X). Before
incubating in broth most of the bacteria were in their endosporal state, and only
few were dead vegetative bacteria. After five minutes, spores started to show signs
of the first stages of germination, corresponding with the degradation of the cortex
(safranine positive indicated with arrows). Within 40 minutes most of the cells were
in their bacillar form. When 6-thioguanosine was added, several spores were still
undergoing early stages of germination, and several did not start germinating yet
(green malachite positive).
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3.2 Half-maximal Inhibitory Concentration of 6-thioguanosine
Following the validation of the 6-thioguanosine protective effect on necrosis, the IC50
for this compound was obtained by the procedures mentioned in sub-chapter 2.11. Cell
viability by PI-DNA fluorescence at four and six hours. The best separation time point
was gotten at 6 hours (figure 26).

A)
4 hours

Relative Intensity

2

6 hours

1.6

1.2

0.8

0.4

0

rol
nt
Co

Relative intensity

B)

Cont rol
2

0,0 μM
0,1 μM

1.6

0,5 μM
1.2

1,0 μM
5,0 μM

0.8

10,0 μM
50,0 μM

0.4

0

4 hours

6 hours

Figure 26. 6-TG protection IC50 assay. Six different concentrations of 6-thioguanosine
were added to J774a.1 cells. Necrosis was monitored at 4 and 6 hours (A
and B). The best separation response was obtained at 6 hours (B). Data
corresponding to 6 hours was used for plotting IC50 regression graph.
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Data points obtained for 6 hours were used to plot four parameter regression curve
using SigmaPlot v. 11. Relative intensity was plotted against the decimal logarithm of
the concentration of 6-TG (figure 27). Results obtained by regression analysis indicated
an IC50 of 3.5 μM, with an R2 of 0.963, and a standard error of the estimate (SE) of
0.221.

2.0
1.8

Relative Intensity

1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
-1

0

1

2

log C (6-TG)/M

Figure 27. Dose-response curve for 6-thioguanosine protective effect on
macrophages J774a.1. The half-maximal inhibitory concentration
corresponded to 3.5 μM.
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3.3 Effect of 6-thioguanine
6-thioguanine (6-Tg) is the corresponding base of the nucleoside 6-TG. Analysis of
the effect of 6-Tg and other bases were performed to determine whether the rybosyl
group was essential for Ger receptor binding or not. Cell viability assays were performed
on J774a.1 cells, and by monitoring germination in vitro. 6-Tg protected germination
after 6 hours (figure 28).
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Figure 28. Effect of 6-Tg in macrophages and in vitro. 6-thioguanine protects
macrophages from B. anthracis mediated killing (A). ‘6-Tg (C)’ is the
control for treatment without spores; it showed that the nucleoside
analogue was not cytotoxic. Surprisingly, after the analysis in vitro
6-Tg did not inhibit germination, when Ino and L-Ala were added (B).
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The results of figure 28 confirm that 6-Tg protected macrophages from necrosis, but
did not prevent germination of the endospores in vitro. The effect of 6-Tg on J774a.1
was corroborated by a direct observation on phase contrast and fluorescence
microscopy (shown in figure 29).

A

B

C

Figure 29. 6-Tg protection on J774a.1 at 6 hours. Upper figures correspond to phasecontrast microscopy, and the bottom ones to fluorescence microscopy of
the corresponding field. Fluorescent dyes were PI (reddish), and DAPI
(blue). ‘A’ is the control of non-infected cells. ‘B’ shows a general necrosis
(PI- positive cells) in non-treated cells after 6 hours of infection with
B. anthracis. ‘C’ images correspond to the protective effect of 6-Tg. The
majority of cells in C was viable; unaltered membranes and no PI staining.

The half-maximal inhibitory concentration was obtained for 6-TG protective effect in
cells. Data obtained at 6 hours was used for plotting regression curve. The value of this
one was obtained by a regression analysis on SigmaPlot, and corresponded to 1,9 μM
with an R2 of the regression of 0.997 (figures 30 and 31).
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Figure 30. 6-Tg protection IC50 assay. Six different concentrations of 6-thioguanine were
added to J774a.1 cells. Necrosis was monitored at 4 and 6 hours, by PI
exclusion assay.
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Figure 31. Dose-response curve for 6-thioguanine protective effect on
macrophages J774a.1. The half-maximal inhibitory concentration
corresponded to 1.9 μM.
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3.4 Effect of 6-chloroguanosine
In the following results, it has been confirmed that 6-chloroguanosine (6-CG) has a
protective effect in J774a.1. After performing a cell killing assay monitored by PI
exclusion assay, there was protection by 6-CG at four hours (figure 32); after 5 hours
treated cells became necrotic. 6-CG protective effect was weaker than the one of 6-TG
and 6-Tg.
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Figure 32. Effect of 6-CG on macrophages J774a.1. After 4 hours 6-CG protective
effect of the analogue was lost and cells became necrotic, shown by the
increase of fluorescence in PI. ‘6-TG (C)’ shows that the analogue was
not toxic to cells.

An IC50 for the effect of 6-CG was obtained as in previous experiments. The data
was obtained after 4 hours with concentrations of 1, 5, 10, 50, 100, and 500 μM. The
regression analysis indicates an IC50 of 0.19 mM, near 100-fold higher than the ones of
6-TG and 6-Tg. The R2 for the regression was of 0.998, with an SE of 0.0612 (figure 33).
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Figure 33.

Dose-response curve for 6-chloroguanosine protective effect on
macrophages J774a.1. Data for plotting was obtained from the 4 hour
time point. The half-maximal inhibitory concentration corresponded to
190 μM.

The IC50 of 6-CG in vitro was obtained by Akoachere et al

(99).

The value of Ki was

used to obtain the IC50 through the modified Cheng-Prusoff equation

(104).

The IC50 of

the inhibition in vitro corresponded to 0.89 mM. Ki value is given in table 4.

3.5 Effect of 6-chloroguanine
6-chloroguanine (6-Cg) is the base of the nucleoside 6-CG. Cell killing assays and
analysis of germination in vitro were performed with 6-Cg, in the same way as previous
experiments. 6-Cg did not prevented the germination in vitro, but protected
macrophages from necrosis with a similar IC50 as 6-CG. These results are given in
(figures 34 to 36).
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IC50 assay for 6-Cg on macrophages J774a.1. The best separation time
point corresponded to 6 hours.
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Figure 35.

Dose-response curve for 6-Cg on macrophages J774a.1. The IC50 of the
regression corresponded to 204 μM. Data points were taken at 6 hours
after infection.
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Figure 36. 6-Tg does not inhibit germination in vitro. The rate of germination
after treating with 1 mM 6-Tg was the same as with Ino (0.25 mM)
and L-Ala (0.04 mM) alone.

3.6 Effect of 6-thioinosine
6-thioinosine prevented cell killing and inhibited the germination in vitro. Both IC50s
were obtained in each case. Results are shown in figures 37 and 38.
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Figure 37.

6-TI IC50 assay on macrophages J774a.1. Data for the
IC50 regression plot was taken at 5 hours.
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Figure 38. Dose-response curve for 6-TI on macrophages J774a.1. The IC50 of the
regression corresponded to 35.2 μM. Data points were taken at 5 hours after
infection. R2 of regression was 0.997.

6-TI was ineffective in inhibiting the germination in vitro Ki for the inhibition in vitro
(99).

Thus, no IC50 was obtained for 6-TI inhibitory effect on endospore germination.

3.7 Effect of 6-mercaptopurine
6-mercaptopurine or 6-Mp is the base that belongs to the nucleoside 6-thioinosine
(6-TI). 6-mercaptopurine showed protection of J774a.1 from spore-mediated killing in
the range of 3-5 hours (figure 39). The IC50 obtained was higher than the one of the
corresponding nucleoside, approaching 0.4 mM. 6-Mp was tested in vitro and did not
alter the germination of the spores with inosine and L-alanine.
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Figure 39. IC50 assay for 6-Mp. The cell killing was monitored between 4-6
hours. The time point that best fitted the IC50 plot was at 4.5 hours.
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Figure 40. Dose-response curve for the protection of 6-mercaptopurine in
J774a.1. The IC50 estimated by the regression analysis was 398
μM. The R2 of the regression was 0.954 with an SE of 0.31.
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6-Mp does not inhibit germination in vitro. The rate of
germination after treating with 1 mM 6-Mp was the same
as with Ino (0.25 mM) and L-Ala (0.04 mM) alone.

3.8 Effect of Allopurinol riboside
The inosine analogue allopurinol riboside (APR) showed a significant protection to
macrophages J774a.1. Contrary to the expectations, it did not inhibit the germination
of the endospores in vitro.
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Figure 42. Protection J774a.1 macrophages by APR. After 5 hours APR
showed a significant protection from necrosis, in contrast with the
non-treated cells. APR was not cytotoxic by itself (APR (C)).
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A dose-response assay for the protection was performed. 5 hours time point was
selected to plot the relative intensities with their respective concentrations. The IC50
obtained by the regression analysis was 646 μM, with an R2 of 0.978 and a SE of 0.159.

2.5

Relative intensity

2.0

1.5

1.0

0.5

0.0

-0.5
0

2

4

6

log C (APR) / M

Figure 43. Dose-response curve for the protection of APR in J774a.1. The
IC50 estimated by the regression analysis was 646 μM. The R2 of
the regression was 0.979, with an SE of 0.16.
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Figure 44. APR does not inhibit germination in vitro. Germinants (Ino and
Ala) were added with 1 mM APR. No significant effect on the
kinetics of the germination was observed.
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3.9 Effect of Allopurinol
Allopurinol (Ap) is the base of the nucleoside APR. This compound did not either
affect the germination of the spores in vitro, or protect the J774a.1 cells from sporemediated killing.
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Figure 45. Effect of Ap on J774a.1 cells. After five hours of treatment Ap did
not prevent macrophages from necrosis. PI-DNA fluorescence
was higher for the two different concentrations of Ap than the
non-treated control. Ap did not show cytotoxicity.
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Figure 46. Ap does not inhibit germination in vitro. Germinants (Ino and
Ala) were added with 1 mM Ap. No significant effect on the
kinetics of the germination was observed.
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3.10 Effect of 6-benzylthioinosine
The next inosine derivative, 6-benzylthioinosine (BTI), showed a considerable
protection from cell killing after 5 hours. BTI is also an inhibitor of the germination in
vitro. M. Akoachere (University of Nevada Las Vegas, 2006) has obtained the IC50 of the
inhibitory effect in vitro, which is 0.0506 mM. This inhibitory effect in vitro can be
correlated with the protection of the macrophages (figure 47).
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Figure 47. BTI protects J774a.1 cells from necrosis after 5 hours. PI
fluorescence in non-treated cells was 1-fold higher than cells
treated with 100 μM BTI. Cytotoxicity by the nucleoside is not
present or minimal; ‘BTI (C)’ shows a similar response to the noninfected cells.

In addition, a dose-response assay was performed to assess the IC50 of the
protective effect on cells. The selected concentrations were 0.5, 1, 5, 10, 50, and 100
μM. A regression curve was obtained with an R2 of 0.996 and SE of 0.166 (figures 48
and 49).

82

A)

B)

5 hours

Relative intensity

4.5 hours

Relative I ntensity

3.5
3.0
2.5
2.0
1.5
1.0
0.5

3.5
3.0
2.5
2.0
1.5
1.0
0.5
0.0

0.0

Co
ntr
ol

4.5 hours
Control
5,0 μM
100,0 μM

0,5 μM
10,0 μM

5 hours
1,0 μM
50,0 μM

Figure 48. BTI IC50 assay. Data was obtained in 4.5 and 5 hours (Figure A). The best
separation corresponded to 5 hours; valid for calculating the regression plot
(Figure B).
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Figure 49. BTI dose-response curve. IC50 was obtained by regression
analysis and corresponded to 1.04 mM.

3.11 Effect of 6-methylmercaptopurine riboside
The compounds analyzed from sub-chapter 3.11 to sub-chapter 3.25 did not protect
macrophages from B. anthracis mediated killing, but did inhibit the spore germination
in vitro. The first of these compounds is 6-methylmercaptopurine riboside (6-MMPR).
Akoachere et al

(99)

showed that 6-MMPR acts as a competitive inhibitor of inosine for

the spore germination, with a Ki of 31 μM (table 4). Its IC50 can be derived from Cheng83

Prusoff16 equation, and has the value of 0.32 mM. 6-MMPR, however, showed little to no
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effect in protecting J774a.1 from necrosis by B. anthracis (figure 50).
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Figure 50. Effect of 6-MMPR on J774a.1 cells after 6 hours. Cell
necrosis was monitored by PI-DNA fluorescence. The rate of
killing in the treated cells was similar to the non-treated
ones.

3.12 Effect of 6-O-methylguanosine
6-O-methylguanosine (6-OMG) inhibited the germination of the spores in vitro. The
Ki obtained by Akoachere et al, was useful to determine the IC50, which belongs to 0.35
mM. 6-OMG does not have a notorious effect on protecting macrophages from necrosis
(figure 51).

16 The Cheng-Prusoff equation correlates the kinetic inhibition constant (Ki) with the halfmaximal inhibitory concentration by expressing that Ki = IC50 / (1 + S/Km), where S is the
substrate concentration, and Km the Michaelis constant of such substrate (104).
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Figure 51. Effect of 6-OMG on J774a.1 cells after 6 hours. Cell necrosis
was monitored by PI-DNA fluorescence. The rate of killing in
the treated cells was similar to the non-treated ones.

3.13 Effect of 2-aminoadenosine
2-aminoadenosine (2-AA) or 6-aminoguanosine inhibited the spore germination in
vitro with a Ki of 68 μM, corresponding to an IC50 of 0.69 mM

(99).

2-AA did not prevent
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the anthrax necrosis within 6 hours (figure 52).
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Figure 52. Effect of 2-AA on J774a.1 cells after 6 hours. Cell necrosis
was monitored by PI-DNA fluorescence. The rate of killing in
the treated cells was similar to the non-treated ones.
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3.14 Effect of PPER
1-(4-(9-(β)-ribofuranosyl)-9H-purin-6-yl)piperazin-1-yl)ethanone

(PPER)

did

not

show protection for J774a.1, but inhibited the germination in vitro (figures 53 and 54).
Its IC50 was obtained following the procedures on sub-chapter 2.12 (figure 55).
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Figure 53. Effect of PPER on J774a.1 cells at 4 and 5 hours. Cell
necrosis was monitored by PI-DNA fluorescence. The rate of
killing in treated cells was similar to the non-treated ones.
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Figure 54. In vitro inhibition of PPER at different concentrations. Germinants
added were inosine (0.25 mM) and L-alanine (0.04 mM). A control
with no germinant was run to test for possible auto-germination. The
maximum concentration of PPER prevented the germination process
almost completely within 45 minutes.
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Figure 55. Dose-response curve for the inhibition of PPER in vitro. Data was
selected for an arbitrary time point. An IC50 of 0.016 mM was
obtained by the regression (R2=0.998 and SE = 0.014).

3.15 Effect of 6-methylaminopurine riboside
6-methylaminopurine riboside (6-MAPR) did not prevent spore-mediated killing on
J774a.1. Germination in vitro was inhibited by 6-MAPR. The following figures show the
IC50 plot as well as the treatment in cells.
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Figure 56. Effect of 6-MAPR on J774a.1 cells at 6 hours. Cell necrosis
was monitored by PI-DNA fluorescence. The rate of killing in
treated cells was similar to the non-treated ones.
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Figure 57. Dose-response curve for the inhibition of 6-MAPR in vitro. Data
was selected from an arbitrary time point. An IC50 of 0.193 mM
was obtained by the regression (R2=0.995 and SE = 0.011).

3.16 Effect of 2-aminopurine riboside
The present analogue (2-APR) inhibited the spore germination in vitro but did not
prevent cell necrosis of J774a.1 cells. Results including the IC50 in vitro are shown in
the following figures.
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Figure 58. Effect of 2-APR on J774a.1 cells after 6 hours. Cell necrosis
was monitored by PI-DNA fluorescence. The rate of killing in
treated cells was similar to the non-treated ones.
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Figure 59. Dose-response curve for the inhibition of 2-APR in vitro. Data
was selected from an arbitrary time point. An IC50 of 0.379 mM
was obtained by the regression (R2=0.990 and SE = 0.016).

3.17 Effect of Xanthosine
Xanthosine (X) did not protect J774a.1 cells from necrosis within 6 hours. Previous
work by Akoachere et al, showed that X is a weak inhibitor in the presence of inosine
and L-alanine; the Ki (777 μM) was significantly higher than other inhibitors (table 4).
The IC50 that correspond to this constant is 7.2 mM. Inhibitory effect from X is only
noticeable at extremely high, non-physiological concentrations.
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Figure 60. Effect of Xanthosine (X) on J774a.1 cells after 6 hours. Cell
necrosis was monitored by PI-DNA fluorescence. The rate of
killing in treated cells was similar to the non-treated ones.
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3.18 Effect of 6-N-benzylmethyladenosine
6-N-benzylmethyladenosine (BMA) did not protect macrophages from necrosis, but
acted inhibiting the germination of the endospores in vitro. An IC50 of the inhibition was
obtained for this compound.
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Figure 61. Effect of BMA on J774a.1 cells at 4 and 5 hours. Cell necrosis
was monitored by PI-DNA fluorescence. The rate of killing in
treated cells was similar to the non-treated ones.
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Figure 62. Dose-response curve for the inhibition of BMA in vitro. Data was
selected from an arbitrary time point. An IC50 of 0.122 mM was
obtained by the regression (R2=0.996 and SE = 0.021).

90

3.19 Effect of 6-N-benzoyladenosine
6-N-benzoyladenosine (NBA) inhibited the germination of B. anthracis spores in vitro.
The corresponding IC50 for the inhibition was obtained. No effect regarding J774a.1
necrosis protection was observed.
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Figure 63. Effect of NBA on J774a.1 cells at 4 and 5 hours. Cell necrosis was
monitored by PI-DNA fluorescence. The rate of killing in treated
cells was similar or slightly higher than the non-treated ones.
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Figure 64. Dose-response curve for the inhibition of NBA in vitro. Data was
selected for an arbitrary time point. An IC50 of 1.142 mM was
obtained by the regression (R2=0.997 and SE = 0.008).

91

3.20 Effect of 6-N-benzylaminopurine
This compound (BAP) was able to inhibit the germination of the spores in vitro, even
though it was lacking the ribosyl group. This is the only ‘base-derivative’ from the set of
compounds that affected the germination rate in vitro. Unfortunately, there was no
correlation with the protective effect on macrophages. No protection was observed
within 4 to 6 hours of infection.
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Figure 65. Effect of BAP on J774a.1 cells at 4 and 5 hours. Cell necrosis was
monitored by PI-DNA fluorescence. The rate of killing in treated cells
was similar or slightly higher than the non-treated ones.
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Figure 66. Dose-response curve for the inhibition of BAP in vitro. Data was
selected from an arbitrary time point. An IC50 of 1.552 mM was
obtained by the regression (R2=0.985 and SE = 0.020).
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3.21 Effect of 6-(γ,γ-dimethylallylamino)purine riboside
The present compound (DMAA) also inhibited the germination of B. anthracis
endospores in vitro. No effect was shown in protecting J774a.1 cells (figures 67 and 68).
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Figure 67. Effect of DMAA on J774a.1 cells at 5 hours. Cell necrosis was
monitored by PI-DNA fluorescence. The rate of killing in treated cells
was similar to the non-treated ones.
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Figure 68. Dose-response curve for the inhibition of DMAA in vitro. Data was
selected from an arbitrary time point. An IC50 of 0.364 mM was
obtained by the regression (R2=0.984 and SE = 0.040).
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3.22 Effect of 6-N-cyclohexyladenosine
6-N-cyclohexyladenosine (CHA) showed an inhibitory effect on spore germination in
vitro. An IC50 for the present analogue was obtained. Treatment with this compound
did not affect the necrotic response on J774a.1 cells (figures 69 and 70).
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Figure 69. Effect of CHA on J774a.1 cells at 5 hours. Cell necrosis was
monitored by PI-DNA fluorescence. The rate of killing in treated
cells was similar or slightly higher than the non-treated ones.
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Figure 70. Dose-response curve for the inhibition of CHA in vitro. Data was
selected from an arbitrary time point. An IC50 of 1.089 mM was
obtained by the regression (R2=0.999 and SE = 0.004).
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3.23 Effect of 6-DPA
6-DPA (6-N-dipropyladenosine) inhibited the germinations of the endospores in
vitro, but was unable to protect macrophages from necrosis. The half-maximal
inhibitory concentration was obtained with a dose-response assay (figures 71 and 72).
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Figure 71. Effect of 6-DPA on J774a.1 cells at 4.5 hours. Cell necrosis was
monitored by PI-DNA fluorescence. The rate of killing in treated
cells was similar or slightly higher than the non-treated ones.
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Figure 72. Dose-response curve for the inhibition of 6-DPA in vitro. Data
was selected from an arbitrary time point. An IC50 of 0.756 mM
was obtained by the regression (R2=0.999 and SE = 0.008).
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3.24 Effect of 6-ECA
6-ECA (6-N-((3-ethylacetyl)cyclohexyl)adenosine) inhibited the germination of B.
anthracis endospores in vitro and its corresponding IC50 was calculated. No noticeable
protection on J774a.1 necrosis was brought out by this analogue (figures 73 and 74).
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Figure 73. Effect of 6-ECA on J774a.1 cells at 4 and 5 hours. Cell necrosis was
monitored by PI-DNA fluorescence. The rate of killing in treated cells
was similar or slightly higher than the non-treated ones.
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Figure 74. Dose-response curve for the inhibition of 6-ECA in vitro. Data was
selected from an arbitrary time point. An IC50 of 0.697 mM was
obtained by the regression (R2=0.999 and SE = 0.006).
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3.25 Cytotoxic Compounds
The following compounds selected from the screening have exerted a moderate to
notorious cytopathic effect on J774a.1 macrophages. Cytotoxicity was assessed through
PI-DNA fluorescence emission, in samples containing non-infected viable cells, with 100
μM of the respective treatment.
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Figure 75. Analogues with cytopathic effect on J774a.1 cells. Fluorescence
emission was taken at 6 hours after infecting with spores. An increase
in relative intensity is observed in treated non-infected cells ‘(C)’, in
comparison with the control non-treated control.

3.26 Other Compounds
The remaining analogues used for the screening did not alter either the germination
of the spores in vitro, or prevented necrosis in the macrophage cell line. The following
table shows the results obtain for each of the compounds in the cell killing assay
(monitored by fluorescence intensity), and in the analysis of germination in vitro.
Concentrations of treatment were 100 μM and 1 mM respectively. Fluorescence readings
were all taken at 6 hours after infecting cells.
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Table 9. Analogues that affected neither germination nor spore-mediated killing
by B. anthracis
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3.27 Analogues that enhanced cell killing
We have identified compounds that upon their addition the macrophages cell killing
rate was moderately enhanced. These molecules did not act as either as ‘germinants’ or
‘inhibitors’ for the germination in vitro, and were not toxic to the cell line. The most
notable compounds in this group were 6-NBA, BMA, IH, and 8-HG (figure 76).
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Figure 76. Killing enhancement of J774a.1 cells. Macrophages were treated with the respective
nucleoside analogues at the dosis of 100 μM (6-NBA, BMA, 8-HG, and IH). The
amount of non-viable cells was higher in the treated samples, in contrast with the
non-treated control. The effect is observable before reaching the saturation time
point (5-6 hours).
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3.28 Cooperative Effect by D-alanine with Nucleoside Analogues
D-alanine is a natural anti-germinant for endospores of B. anthracis. This molecule
can be synthesized by the alanine racemase present in the spore, and block
germination pathways involving L-alanine as a germinant. Two research groups have
already shown that D-alanine protects macrophages from B. anthracis toxin-mediated
necrosis, by inhibiting the germination of the endospores inside the phagosome, and
subsequent killing of the spores by the macrophages

(97,98).

If L-alanine triggers the

germination receptor GerL, then D-alanine will likely bind the same receptor. In the
present investigations we corroborate the protecting results of D-Ala by obtaining halfmaximal inhibitory concentrations for the germination in vitro and for the J774a.1
killing protection. IC50 assays were performed as in previous experiments (figures 77
and 78).
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Figure 77. Dose-response curve for necrosis protection of J774a.1 by Dalanine. Data was taken at 4.5 hours of infection. An IC50 of 22.9
μM was obtained by regression analysis (R2=0.999 and SE =
0.008).
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Figure 78. Dose-response curve for the inhibition of D-Ala in vitro. Data was
selected from an arbitrary time point. An IC50 of 0.016 mM was
obtained by regression analysis (R2=0.974 and SE = 0.019).

The germination inhibition by D-Ala was also observed at light microscopy (figure
79). The following pictures illustrate the efficiency of the amino acid in preventing the
germination after incubating the spores for 40 minutes in Luria-Bertani broth.

A

B

C

D

Figure 79. Effect of D-alanine observed at light microscopy. B. anthracis spores were incubated
in LB broth, and samples were stained by Schaeffer-Fulton method. At time 0 (figure
A) no germinating spores were observed. After five minutes in broth (B) some spores
were already undergoing the first stages of germination. After 40 minutes in broth
germination was completed for the majority of spores (C). Broth containing 10 mM
D-alanine inhibited the germination considerable after 40 minutes (D).
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The germination of B. anthracis takes place in the presence of extremely high
concentrations of L-alanine. Nevertheless, only when L-Ala is combined with a
nucleoside or another amino acid, germinants may act at physiological concentrations.
A combination of two inhibitors, one nucleoside (6-TG) and one amino acid (D-Ala),
could act in synergy inhibiting different pathways of germinations combined. A cell
killing assay was performed with D-Ala and 6-TG at sub-optimal concentrations. Each
of these in inhibitors for separate was not able to protect cells from necrosis at 6 hours.
Combined together they showed a cooperative effect, protecting J774a.1 cells from
toxin-mediated killing (figure 80).
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Figure 80. Cooperative effect of D-Ala and 6-TG. Six hours after infecting
macrophages each of these inhibitors at sub-optimal
concentrations failed to protect cells from necrosis (PI-DNA
fluorescence increased near 4-fold from non-infected control).
These compounds combined together at the same concentrations
protected cell damage considerably.

Similar assays were performed with D-alanine in combination of two other
nucleosides that prevented necrosis in cells: 6-TI and 6-CG (figure 81). A moderate
cooperation with the amino acid was observed; the synergy shown was not as important
as the one in previous experiment with 6-TG. These results confirm the hypothesis that
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two anti-germinants of different nature (nucleoside and amino acid) enhance the
protection of each of the anti-germinants alone.
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Figure 81. Cooperative effect of two nucleoside anti-germinants and D-Ala. Chart A
shows effect of 6-TI, and chart B the effect of 6-CG. Five hours after
infecting macrophages, each of these inhibitors at sub-optimal
concentrations failed to protect cells from necrosis. When the nucleosides
were treated in combination with D-Ala, necrosis response was
diminished at that time.
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3.29 Summary of Results
The following table represents the half-maximal inhibitory concentrations obtained
for each of the analogues that protected J774a.1.

Table 10. Compounds that protect J774a.1 cells from B. anthracis-mediated killing.
Name

Acronym

Structure

6-thioguanosine

6-TG

0.0035

6-chloroguanosine

6-CG

0.1894

6-thioinosine

6-TI

0.0351

Allopurinol riboside

APR

0.6461

6-benzylthioinosine

BTI

1.0449

6-thioguanine

6-Tg

0.0018

6-chloroguanine

6-Cg

0.2040

6-mercaptopurine

6-Mp

0.3981

D-alanine

D-Ala

0.0229
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The following table represents the half-maximal inhibitory concentrations obtained
for each of the analogues that inhibited the spore germination in vitro.

Table 11. Compounds that inhibited germination B. anthracis endospores in vitro.
Name

Acronym

Structure

6-thioguanosine

6-TG

1.0054

6-chloroguanosine

6-CG

0.8925

6-benzylthioinosine

BTI

0.0506

6-methylmercaptopurine
riboside

6-MMPR

0.3180

6-O-methylguanosine

6-OMG

0.3488

2-aminoadenosine

2-AA

0.6977

Xanthosine

X

7.1914

6-methylaminopurine
riboside

6-MAPR

0.1932

2-aminopurine riboside

2-APR

0.3793
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Table 11. Compounds that inhibited germination B. anthracis endospores in vitro (continued from
last page).
Name

Acronym

Structure

1-(4-(9-(β)-ribofuranosyl)9H-purin-6-yl)piperazin-1yl)ethanone

PPER

0.0511

6-Nbenzylmethyladenosine

6-BMA

0.1218

6-N-benzylaminopurine

BAP

1.5524

6-(γ,γ-dimethylallyl
amino)purine riboside

DMAA

0.3642

6-N-benzoyladenosine

NBA

1.1426

6-N-cyclohexyladenosine

CHA

1.0890

6-N-dipropyladenosine

6-DPA

0.7556

6-N-((3ethylacetyl)cyclohexyl)
adenosine

6-ECA

0.6966
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CHAPTER 4
DISCUSSION
4.1 J774a.1 killing by Bacillus anthracis
The present study confirms that mammalian macrophages J774a.1 can readily
phagocyte endospores of B. anthracis. Direct observation through phase-contrast
microscopy shows that after infecting with an m.o.i. of 5, phagocytosis takes place in a
time of 60 to 90 minutes. Washing cells and replacing medium at 80 minutes removes
most of the free spores in the medium that were not phagocytosized. Spore germination
within the macrophages occurs within 2-3 hours after infecting. Germinated spores lose
their characteristic birefringence, but their oval-shaped morphology remains the same.
It is not until the spore maturation when necrotic macrophages started to appear, after
3-4 hours; protein expression starts at stage 5 of germination (subchapter 1.4.1). Toxin
activity does not come until spores are germinated. Action by LF/EF is essential for the
survival of the germinated spore inside the macrophage.

(27).

Germinated bacilli were

able to kill and escape from the cell. An ultimate cell-lysis led by the action of the
anthrax toxins allows freedom of vegetative bacteria, and their rapid proliferation in
DMEM medium.
It is not clear, however, if killing took place by necrosis, apoptosis, or a combination
of both. Recent studies found that LF can induce either caspase-1 mediated necrosis or
apoptosis, depending on the macrophage genotype. Bone marrow derived macrophages
(BMMs) from mouse strain BALB/c undergo a rapid necrosis by LF

(105).

J774a.1 comes

from the same mouse strain. Killing response in these cells is fast: when necrosis starts
there is a lag-phase from 3 to 4 hours. Within an hour the signal from PI-DNA reaches
saturation at 5 hours (figure 82). Thus, most of the cells are killed within one hour
approximately. This fast killing is more likely to be a necrosis instead of apoptosis.
Rapid apoptosis led by LPS or disruption Mek3/6 MAP-kinases pathways occurs in
certain macrophages or dendritic cells within 8 hours at least. On the other hand, EF is
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not cytotoxic by itself, but alters cell homeostasis by increasing cAMP

(46).

Both toxins

together contribute synergistically to cytotoxicity inside the macrophages.

Control
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Figure 82. Killing of J774a.1 within time. After 3 hours of infection,
there is no significant increase in fluorescence intensity
by PI-DNA. Some killing started at 4 hours and within
an hour a maximum fluorescence signal is reached, that
correlates with a fast necrotic response led by the
anthrax toxins.

4.2 Structure activity relationships
The data in chapter 3 confirms the protective action of the nucleoside 6-TG against
the spore germination and subsequent toxin-mediated killing of macrophages. Few
analogues derived from 6-TG have also exerted protection with higher IC50 than the first
one. Among the nucleoside compounds, 6-CG, 6-TI, APR, and BTI were found to show a
protective effect in cells. These compounds all have in common a sp3 hybridized
exocyclic atom in position 6 of the purine base, with the exception of APR. 6-TG and 6CG are guanosine derivatives with an amino group as substituent in position 2 of the
ring.
Analysis of half-maximal inhibitory concentrations of compounds that inhibit cell
necrosis shows that those compounds having an exocyclic 2-amino are stronger
inhibitors than those that do not have. The difference between 6-thioguanosine and 6110

thioinosine is the 2-amino of the ring; the first one has the amino group and an IC50
100-fold smaller than the last one. An analogous example is the effect that exerts 6-CG
and 6-CPR. Both have an exocyclic atom of chlorine in position 6, although the first has
also the 2-amino. The first one protects cell killing at an IC50 near 0.9 mM, where as the
other has no effect in cells or in vitro. We may conclude that 2-amino shows a
significant interaction with the receptor that enhances inhibitory effect. Compounds
with an un-substituted 2 position may act as inhibitors, depending on the effect exerted
by the 6 position group. On the other hand mono-substituted purine with 2-amino
inhibits germination in vitro but not in cells (2-APR), which means that 2-amino exerts
inhibitory action by its own, without the contribution by the group at position 6.
An amino group in position 2 suggests the possibility of a dipole-dipole electrostatic
interaction with residues in the binding pocket of the receptor. Other groups in this
position, such as 2-oxo, (X, IG) had little to no effect in the germination inhibition in
vitro. The type of interaction should be a bifurcated hydrogen bonding, being the two
hydrogens of the amino groups the possible donors. We hypothesized the hydrogen
bonding type because it is a strong intermolecular interaction; adding a 2-amino
increases the inhibitory potency considerably. Other possible lower energy forces
electrostatic can be ruled out in this case.
Results show that position 6 is even more relevant for the inhibition than 2-amino.
All of the compounds that prevented spore germination in cells have an exocyclic group
in position 6. This group contains an electronegative atom bonded to the C6 of the
purine with sp3 hybridization. Chemical properties of this group will contribute or
hinder the inhibitory effect. The facts that affect the inhibition potency conferred by 6position of the ring are the following:
a) Electronegativity. – The atom linked to C6 from the exocyclic group is usually an
electronegative element (O, Cl, N, or S). E. Abel-Santos et al (in press) showed
that 6-group electronegativity is correlated to the inhibition constant (Ki) of B.
cereus spore germination; Log (Ki) decreased in a lineal relationship with electro111

negativity of the group. Results obtained in B. anthracis showed no correlation
(table 12).

Table 12. Electronegativity of some C6-groups compared to
IC50s in vitro
Ki /mM
IC50 / mM
Electronegativity†
Chemical group
(B. cereus)§
(B. anthracis)
-OCH3
3.09
0.112
0.35
-N(CH3)2
2.78
0.025
N/A
-N(H)CH3
2.74
0.017
0.19
0.31
-SCH3
2.52
0.008
† Values given by ‘super atom’ approximation based on the Pauling scale.
§Data provided by Dr. E. Abel-Santos, University of Nevada Las Vegas (not published yet).

Although electronegativity is relevant, we conclude that there was no direct
relationship between electronegativity and IC50 for inhibiting B. anthracis
endospore germination. Furthermore, electronegativity-IC50 cannot be correlated
for protective effects in cells either. The results showed that any in vitro inhibitor
having nitrogen as the electronegative element (adenosine derivates) did not
protect macrophages from necrosis. Compounds that protected cells from killing
have S, Cl, or O. The most notable difference between these elements and
nitrogen is that the latter one has a valence of 3. Compounds having protective
effect contained electro-poor atoms with a valence of 1 or 2. Nitrogen may be
linked to the C6 and have other two side chains; the remaining electronegative
elements will have one or no side chains. It would be possible to consider that
there is steric hindrance for this fact; but even the 6-N derivatives that have one
side chain solely (6-MAPR) did not show any effect on cells as they did in vitro. A
hypothesis to explain this situation is that adenosine derivatives show affinity
for another enzyme implicated in the nucleoside metabolism of the mammalian
cell; these analogues will be either chemically transformed, or will bind
irreversibly to a protein or enzyme in the cell, obstructing them from inhibiting
Ger receptor activation.
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These premises lead to hypothesize that 6-group inhibitory potency relies on the
strength of the dipole moment created by the electronegative element. The best
inhibitors have a relatively low electronegativity in 6-group (C6-SR, C6-SH, C6NR) leading to dipole-dipole interactions. On the other hand, germinants have a
strong polarity in the 6-substituent conferred by the presence of highly
electronegative

atoms

(C6=O,

C6-NH2)

leading

to

stronger

electrostatic

interactions of the hydrogen bonding type. 6-group is likely to be a hydrogen
bond acceptor of a donor belonging to side chains of residues from the binding
pocket. This hydrogen bonding will induce a conformational change in the
receptor, triggering its activation and germination signaling.
b) Sp3 hybridization. – The electro-poor atom that is bonded to C6 of the ring must
have a sp3 hybridization to inhibit receptor activation. When the orbital
hybridization of this atom is of sp2, such as in the 6-oxo group (guanosine,
inosine, xanthosine, immucillin H), the analogue will trigger, more or less, spore
germination in vitro (APR is the only exception to this rule). Even though 6-oxo
shows keto-enol tautomerism in purine bases, 3H-enol forms are less abundant
in physiological conditions

(107).

Enol forms (-OH) have a sp3 orbital

hybridization but concentrations are minimal, showing no significant inhibitory
effect in vitro or in cells. In the case of 6-OMG, there is an oxygen atom bonded
to a methyl group (-OCH3), and having a sp3 orbital: this compound decreases
the germination rate in vitro. We conclude that sp3 hybridization of the atom
directly connected to C6 of the purine is required for 6-groups to hinder the
activation of the Ger receptor.
c) Length and morphology of the side chain. – The 6-exocyclic side chain extension
does not necessarily cause an steric hindrance for ligand-receptor binding. Most
of the compounds having side chains at 6-position, bound to an electronegative
atom (C6-S-R, C6-N-R, C6-O-R) inhibited the in vitro endospore germination
efficiently, no matter the length of these chains. Bulky side chains from
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adenosine derivatives hindered germination in vitro but not in cells, whereas
long side chains of 6-thioinosine derivatives (6-BTI) also prevented germination
within the macrophages.
Strikingly, analogues with small side chains (6-MAPR, 6-OMG, 6-MMPR) showed
no protection on cells, even though they hampered in vitro germination. 6-MMPR
has a methyl side chain, and 6-BTI has benzyl group; the first one does not
prevent germination within macrophages, in contrast with the second one. In
vitro, their IC50 are approximately 50 μM for 6-BTI, and 320 μM for 6-MMPR;
this suggests the existence of interactions of either London dispersion forces, or
π-π stacking with the benzyl group, that increase affinity of the analogue with
the receptor.
Analogues having tertiary amine at C6, inhibited germination with the presence
of bulky side-chains (6-DPA, BMA, ECA, CHA, PPER), but showed little to no
effect with small side groups, like methyl (6-DMA). Tertiary amines have lower
polarity. The fact of having bulky groups as substituent is possibly adding more
interactions (London dispersion forces, π-π stacking), that increase ligandreceptor affinity. 6-DMA (C6-N-(CH3)2) does not hinder germination, contrary to
6-MAPR (C6-NH-(CH3)): the latter one has a higher polarity, allowing a stronger
dipole-dipole interaction. 6-DPA has similar polarity to 6-DMA, although the first
inhibits germination (IC50=0.75 mM). 6-DPA propyls have a stronger Van Der
Waals interactions than metyhls from 6-DMA. To summarize these ideas, we
conclude that the size of the 6-exocyclic group does not add steric hindrance for
the binding with the germination receptor, and interactions from additional
forces by bulky groups may increase the affinity of the analogue.
d) Hydrophobicity. – Solubility and size of the molecule seems to be relevant for the
diffusion of the compound in cells. The best example is given by the protective
action of 6-TG and 6-BTI, both having an exocyclic sulfur group. 6-TG, with a
non-substituted thiol at position 6, has an IC50 of 3.5 x 10-3 mM for the
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inhibition of cell necrosis. 6-BTI has a benzyl side chain, and its IC50 is near 1
mM; a thousand times higher than 6-TG. Partition coefficients (LogP)17 are -0.43
and 1.18 for 6-TG and 6-BTI respectively. Strikingly, in vitro, this inhibitory
potency is inverted, with 6-BTI having and IC50 1000-fold smaller than 6-TG (50
to 1000 μM). Hence, 6-BTI has a higher affinity for the receptor, since more
intermolecular forces are implicated, albeit it has a limited diffusion or solubility
in cell medium due to its high hydrophobicity and size. 6-MMPR has IC50 of 0.32
mM in vitro, but a LogP of 0.02; this implies that its solubility in cell medium
limits the concentration available for cell diffusion. Even though 6-BTI has less
solubility, its IC50 is 100-fold smaller than the one of 6-MMPR.
In addition to the 2 and 6 substitutions in the purine, other structural facts from
the nucleosides are to be considered. The importance of the ribosyl sugar that binds
the N9 of the purine was assessed by using ribosyl-free compounds and a modified 9-N
non-sugar substituent (GCv). It was found that the 9-N-ribosyl is required for the
inhibition of the germination in vitro. None of the purine base derivates studied (6-Tg, 6Cg, 6-Mp, Ap, 6-CyP, 2-MBI, 2-MMBI) were able to affect germination with only one
exception: benzylaminopurine (BAP). BAP was the only base screened having a side
chain attached to N6. Compared to the other bases, BAP is likely to have additional
interactions of the type of π-π stacking by the benzyl group, or induced dipoles (London
dispersion forces). Surprisingly, results in vitro did not correlate with the screening in
J774a.1 macrophages. 6-Tg, 6-Cg, and 6-Mp are the bases that correspond to the
nucleosides 6-TG, 6-CG, and 6-TI respectively. These bases exerted a moderate to high
protection of cells from necrosis.

Some studies have found that 6-Tg and 6-Mp are

transformed into 6-TG-monophosphate (6-TGMP), and 6-TI-monophosphate (6-TIMP) in
lymphoma cell lines, by the enzyme hypoxanthine-guanine phosphoribosyl transferase

17

LogP is defined as the partition coefficient of an un-ionized compound, given by the ratio of the
concentration of solute in octanol divide by the concentration of the solute in water. (LogP = Log
([solute]octanol/[solute]water). It is used in organic chemistry and pharmaceutical sciences to
measure the hydrophobicity of a substance.
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(HGPRT)

(108, 109).

We suggest that also 6-Cg may be transformed to 6-CGMP. The

presence of the 5’-nucleotidase-I in the cytososol

(110),

promotes the degradation of

monophosphate nucleotides to nucleosides. Thus 6-TGMP, 6-CGMP, and 6-TIMP are
converted to the nucleoside 6-TG, 6-CG, and 6-TI respectively, which inhibit spore
germination inside the phagolysosome (figure 83).

6-Tg

Cytosol

6-Mp
6-Cg
HGPRT

6-Tg
6-Mp
6-Cg

6-TIMP
PRPP

Nucleotidase

PPi 6-CGMP

6-TG
H2O

Figure 83.

Phagosome
containing
spore

6-TGMP

6-TI
Pi

6-CG

Purine base derivates inhibit spore germination inside the
cell. Bases are converted into their respective nucleosides, by
a two-step enzymatic catalysis.

The ribosyl groups are necessary for the optimal ligand-receptor binding. Hydrogen
bonding between the hydroxyl groups and amino acid residues is possible. Gancyclovir
(GCv) contains a 9-N substituent different than a ribose sugar. It has 2-hydroxy groups
that may interact electrostatically, in a similar way to hydroxyl groups of the ribose.
Analysis in vitro did not show a significant contribution by GCv; it did not trigger or
inhibit germination. The plane formed ribose is perpendicular to the base, and distance
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between hydroxyl groups is different than in GCv. Thus, conformational disposition of
hydroxyls is relevant for the hydrogen bonding interactions.
Substitutions in 7 or 8 position of the purine ring (7-MI, 8-HG) had little to no effect
on germination. Groups in those positions could present steric hindrance for the
binding with the catalytic pocket or the receptor, impeding the binding to the receptor.
Disposition of nitrogen hetero-atoms among the ring does not necessarily hinder
binding, but decreases affinity considerably. APR and IH had no significant effect on
spore germination in vitro; both have a 6-oxo (similar to inosine) but lacking N heteroatom at position 7. Then, N7 of the purine should contribute to interactions with the
binding site.
Finally, the possibility that the six-member pyridine type ring has inhibitory effect
by its own can be ruled out. Pyridine derivatives (2-MPm, 2-TU, TTCA, DAMPm, 2-MPy,
4-MPy) did not affect spore germination or protected cells from killing. The sulfur group
does not inhibit germination by its own either (β-mercaptoethanol). Therefore, the
integrity of the purine ring is essential for triggering or blocking the germination
receptor activation.
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R

A

B

B

B

Figure 84. Model for nucleoside recognition by the receptor GerH in B. anthracis.
Hydrogen bonding interactions are represented by the red arrows. Direction
of these arrows indicates the hydrogen acceptor. Double-sense arrows show a
hypothetical bonding in which acceptor-donor is not defined. ‘B’ refers to
bulky residues that sterically restrict nucleoside binding. ‘A’ represents an
aromatic residue for a potential π-π stacking with the C6 side chain. ‘X’ is an
electronegative element and ‘R’ is a bulky side chain. The presence of a Hbond with X induces a conformational change in the catalytic pocket,
triggering Ger receptor activation.

4.3 Exceptional Cases: 6-TI and APR
The obtained data reveals that 6-thioinosine (6-TI) hindered cell necrosis, with an
IC50 of 35 μM approximately. In vitro, 6-TI does not have a significant interaction with
the spore germination of B. anthracis

(99).

These results suggests that 6-TI itself have

little to no affinity to the receptor. Electronegativity of the ‘mercapto’ group and thioderivates is moderately smaller than alcohols or amines. A decreased dipole moment of
‘mercapto’ groups diminishes the dipole-dipole interactions with the receptor. In
addition, the lack of amino group substituting the C2 of the ring reduces hydrogen
bonding interactions with the binding site. 6-TI and 6-MMPR are very close structures.
Although electronegativity of their 6-substituent is similar, 6-TI have a higher solubility
in medium (LogP = -0.81) than 6-MMPR (LogP = 0.02). 6-TI can be diffused easier than
6-MMPR due to a lower molecular weight and higher solubility in in water; however 6-TI
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does not inhibit spore germination. Since there is no possible steric or solubility
hindrance, we suggest that 6-TI will actually bind the Ger receptor with a lower affinity
than germinants and slightly trigger spore germination, due to a weak dipole interaction
by the ‘thio’ group.
6-TI exerts protection in cells in contrast with the results obtained in vitro. 6-TI is
likely to undergo enzymatic transformation. 6-TI is very similar to inosine. In the
metabolism of nucleotides, inosine mono-phosphate (IMP) is oxidized to xanthosine
monophosphate (XMP) by IMP-Dehydrogenase. XMP is subsequently transformed to
guanosinie monophosphate (GMP) by GMP-synthase

(111).

Nucleosides entering to the

cytosol are converted to mono-phosphate nucleotides by the nucleotide kinases: 6-TI is
converted to 6-TIMP. 6-TIMP may undergo the same reactions as IMP, due to a minimal
structural difference. 6-TIMP is oxidized to 6-thioxanthosine mono-phosphate (6-TXP),
and finally converted to 6-TGMP. 6-TGMP is degraded to 6-TG by cytosolic or lysosomal
nucleotidases. 6-TG will then inhibit spore germination. The mechanism is shown
below:

IMP-DH

NK
6-TI

6-TIMP
ATP

ADP

6-TXMP

NAD+

NADH

+ H2O

Gln +
ATP

GMPS

Nucleotidase

Glu +
ADP + Pi

6-TGMP

6-TG
Pi

Allopurinol riboside (APR) is a peculiar case.

H2O

This purine nucleoside analogue

shows a moderate protective effect in the macrophage cell line, having an IC50 close to
0.65 mM. APR shows no effect on the germination in vitro, and its base (Ap) does not
hamper spore germination in vitro or inside the cells. APR is likely to be modified
ezymatically in vivo into another compound that binds and inhibit spore germination.
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APR has been used a drug to inhibit the growth of the protozoans Leishmania sp. and
Trypanosoma

sp.

in

humans

(112,

113).

This

compound

is

converted

to

4-

aminopyrazolo(3,4-d)pyrimidine riboside or aminopurinol riboside (AmPR), which is
incorporated to the RNA, being toxic for the promastigotes. APR is selectively toxic
because it is not catalyzed by the same enzymes in humans

(112),

or in mouse

(114).

In

mammalian cells, APR is metabolized to IMP analogues, whereas in the protozoan APR
is converted either to ATP or GTP analogues. We suggest that APR, which has a strong
homology with inosine, will be catalyzed by the same enzymes that convert IMP into
GMP

(IMP-deydrogenase

and

GTP-synthase),

leading

to

the

analogue

2-

aminoallopurinol riboside mono-phosphate (2A-APRMP). Alternatively, APRMP could be
catalyzed into aminopurinol mono-phosphate (AmPRMP) by adenylsuccinate synthetase
and adenylsuccinate lyase. Either 2A-APR or AmPR may be acting as inhibitors for B.
anthracis germination. Further investigations with these two analogues in vitro will be
required.
Allopurinol (Ap), the corresponding base for APR, is a drug used for the treatment of
hyperuricemia

(115).

The base has no effect regarding the germination triggering or

inhibition. It is a structural isomer of hypoxanthine, and efficiently inhibits the enzyme
‘Xanthine oxidase’, obstructing the pathway for the synthesis of uric acid. Ap may also
undergo the savage pathway catalyzed HGPRT, and be converted into APRMP

(116).

Ap is

mostly converted into oxypurinol by xanthine oxidase, rather than APR. Only 10% of
the Ap is converted to APR

(117).

These findings demonstrate that only extremely high

concentrations of Ap will lead to significant concentrations of APR to prevent spore
germination inside the macrophages.
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IMP-DH

NADH

NK
APR

APRMP
ATP

PPi

ADP

GTP

Gln +
ATP

2A-APRMP

Glu +
ADP + Pi

NAD+
+ H2O

2A-APR

Nucleotidase
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APSMP
Fumarate
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Figure 85. Hypothetic mechanism for the enzymatic transformation of APR in mammalian cells.
The corresponding abbreviations are Ap (allopurinol), APR (allopurinol riboside), PRPP
(5-phospho-α-D-ribosyl-1-pyrophpate), NK (Nucleotide kinase), XO (xanthine
oxydase), HGPRT (hypoxanthine-guanine phophoribosyl transferase), APRMP
(allopurinol mono-phosphate), ORPMP (oxypurinol mono-phosphate), IMP-DH
(inosine mono-phosphate dehydrogenase), GMPS (guanosine mono-phosphate
synthetase), ASS (adenylo-succinate synthetase), APSMP (allopurinoyl succinate
mono-phosphate), ASL (adenylosuccinate lyase), 2A-APR (2-aminoallopurinol
riboside), AmPR (Aminopurinol riboside).

4.4 Inhibitors or Weak Germinants
It was previously mentioned that nucleoside derivatives are competitive inhibitors of
germinants (sub-chapter 1.5.1). In our studies, anti-germinant protection in J774a.1
only lasted for a period comprehended in 6 hours approximately. After certain amount
of time, endospores in treated cells started to germinate, eventually leading to a rapid
necrosis of the macrophages. Nucleoside anti-germinants are not fully inhibiting but
slowing the kinetics of the germination. Each compound shows a varying pattern of
protection in time. 6-TG and 6-Tg were the stronger inhibitors. Event though they
impeded cellular necrosis within 6 hours of infection, after that time was passed, there
was an increasing number of necrotic cells. Weaker inhibitors, such as 6-TI or 6-CG,
protected more or less within 5 hours, and at 6 hours most of the treated cells lost their
viability (figure 86).

121

4 .0

2 .5

2 .5

Relative Intensity

4 hours
2 .0

2 .0

3 .0

1.5

6 hours

1.5
2 .0

1.0

1.0
1.0

0 .5

0 .5

0 .0

0 .0

Control

Spores

6-T g 50 μM

0 .0

Control

Spores

6-T I 100 μM

Control

Spores

6-CG 100 μM

Figure 86. Eventual loss of protection by the nucleoside anti-germinants. Protective effect
may last up to 6 hours in strong inhibitors (6-Tg). In weaker inhibitors (6-CG,
6-TI), the kinetics of cell killing slowed down in contrast with the non-treated
cells; after 6 hours, most of the cells were killed.

From these observations, we propose that nucleoside inhibitors can be considered
weak germinants. Since the hydrogen bonding interaction with the 6-exocyclic group is
the key to trigger receptor activation, it can be inferred that anti-germinants have a
group with less electronegativity and lower dipole moment that diminishes the strength
of

the

hydrogen

bonding

interaction.

Nevertheless,

dipole-dipole

electrostatic

interactions are possible; this will trigger certain conformational change in the pocket to
activate the receptor. This activation is, however, considerably less than the one by
natural nucleoside germinants (inosine, guanosine, and adenosine), and other
nucleoside analogues having a higher polarity in the 6-group (IG, X, APR, 6-CPR).

4.5 Inhibitory Contribution by D-alanine
Results included in sub-chapter 3.27 demonstrate a cooperative effect existing with
the interaction of D-alanine and nucleoside inhibitors: 6-TG protected macrophages at
sub-optimal concentrations in combination with D-alanine, in contrast with the
nucleoside alone. This finding fits into the multiple-pathway model for B. anthracis
germination activation proposed by P. Hanna and colleagues

(68),

addressed in sub-

chapter 1.4. D-alanine inhibits the GerL receptors, which contribute to at least three
different pathways: Alanine pathway, AAID-1 (amino acid and inosine dependent
pathway), and AEA (aromatic amino acid enhanced alanine pathway). Nucleoside
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inhibitors bind the receptor GerH, hindering AAID-1 and AAID-2 pathways. Then, we
have an additional pathway (AAID-2) that is blocked by the nucleoside analogues.
Furthermore, the mixture of nucleoside anti-germinants and D-alanine will block the
AAID pathway via GerX activation, considering that contributions by this receptor are
relevant for spore germination within the macrophages

(26).

In addition, Hanna’s multiple-pathway model states that two or more pathways
activated by germinants contribute synergistically to the rate of germination of the
endospore. The present work corroborates such principle with the finding that two
inhibitors affecting more than one pathway will show a cooperative effect in preventing
germination and cell killing of macrophages.

4.6 General Conclusions and Further Work
The present study has conducted an extensive screening in a wide variety of
nucleoside analogues, to identify their effect on the germination of B. anthracis
endospores. Besides clarifying previous work on the germination inhibition in vitro, new
insights have been gained on the mechanism of germination inhibition inside
mammalian cells. An exhaustive analysis of the data provided sufficient information to
determine relevant molecular interactions involved in the binding of the ligand with the
germination receptor. Our findings elucidate a plausible model for receptor activation,
in which the conformational change in the receptor is induced by a crucial hydrogen
bonding interaction with the 6-exocyclic group of the purine ring.
This model corresponds with the idea that nucleoside inhibitors do not impede the
germination per se, but affect the velocity of the receptor activation, behaving as weak
germinants. The establishment of a hydrogen bonding between C6-electronegative
element of the nucleoside and the residue of the active site is given by the dipole
moment of such element. When such polarity is not enough to create an electrostatic
interaction of hydrogen bond type, the molecule will bind the active site without
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triggering the conformational change in the receptor. Thus, we consider inhibitors as
weak germinants with light dipole interactions may lead to sporadic activation
Further work on this area should be done for validating these hypotheses. The
characterization of GerHA protein is recommended, in order to elucidate the threedimensional conformation and motifs that shape the active site. Characterization
should be achieved by the performance of studies of x-ray crystallography and mass
spectrometry. Such information will reveal the identity of the residues that are involved
in the binding with the purine nucleosides.
Investigation on antigerminants for B. anthracis should continue. This work must
be aimed in the finding of a stronger and non-toxic inhibitor as an immediate
prophylaxis to stop anthrax pathogenesis. It is recommended a chemical synthesis for a
nucleoside derivate having a strong affinity for the GerH receptor, but without polarity
in the 6-exocyclic chain; lacking the electro-poor element. Such molecule should be able
to block the binding site without interacting with the catalytic residues that trigger the
receptor activation.
Perfecting anti-germination drugs will contribute significantly with biodefense
concerns. These drugs could represent the must immediate antidote against the
commencement of anthrax pathogenesis upon the inhalation of the spores. The
development of novel antigerminant agents may even serve as new approach for
prophylaxes against diseases caused by other sporulating bacteria. Such treatment
could be efficient for preventing severe systemic infections by Bacillus and Clostridium
genera, including tetanus and CDAD.
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